In	O
vitro	O
suppression	O
of	O
programmed	O
cell	O
death	O
of	O
B	B-cell_type
cells	I-cell_type
by	O
tissue	O
inhibitor	O
of	O
metalloproteinases-1	B-protein
.	O

Cellular	O
pathways	O
for	O
induction	O
of	O
programmed	O
cell	O
death	O
(	O
PCD	O
)	O
have	O
been	O
identified	O
,	O
but	O
little	O
is	O
known	O
about	O
specific	O
extracellular	O
matrix	O
processes	O
that	O
may	O
affect	O
apoptosis	O
along	O
those	O
pathways	O
.	O

In	O
this	O
study	O
,	O
a	O
series	O
of	O
Burkitt	B-cell_line
's	I-cell_line
lymphoma	I-cell_line
(	I-cell_line
BL	I-cell_line
)	I-cell_line
cell	I-cell_line
lines	I-cell_line
were	O
assayed	O
for	O
their	O
expression	O
of	O
tissue	B-protein
inhibitor	I-protein
of	I-protein
metalloproteinases	I-protein
(	I-protein
TIMP	I-protein
)	I-protein
-1	I-protein
.	O

Results	O
indicate	O
that	O
TIMP-1-positive	B-cell_line
BL	I-cell_line
lines	I-cell_line
show	O
resistance	O
to	O
cold-shock-induced	O
apoptosis	O
.	O

Furthermore	O
,	O
recombinant	O
TIMP-1	B-protein
,	O
but	O
not	O
TIMP-2	B-protein
or	O
a	O
synthetic	O
metalloproteinase	O
inhibitor	O
(	O
BB-94	O
)	O
,	O
confers	O
resistance	O
to	O
apoptosis	O
induced	O
by	O
both	O
CD95-dependent	O
and	O
-independent	O
(	O
cold	O
shock	O
,	O
serum	O
deprivation	O
,	O
and	O
gamma-radiation	O
)	O
pathways	O
in	O
TIMP-1-negative	B-cell_line
BL	I-cell_line
lines	I-cell_line
.	O

TIMP-1	B-protein
suppression	O
of	O
PCD	O
is	O
not	O
due	O
to	O
metalloproteinase	B-protein
inhibition	O
,	O
as	O
reduction	O
and	O
alkylation	O
of	O
the	O
TIMP-1	B-protein
did	O
not	O
abolish	O
this	O
activity	O
.	O

Retroviral	O
induction	O
of	O
TIMP-1	B-protein
not	O
only	O
resulted	O
in	O
cell	O
survival	O
but	O
also	O
in	O
continued	O
DNA	O
synthesis	O
for	O
up	O
to	O
5	O
d	O
in	O
the	O
absence	O
of	O
serum	O
,	O
while	O
controls	O
underwent	O
apoptosis	O
.	O

This	O
resistance	O
to	O
apoptosis	O
is	O
reversed	O
by	O
anti-TIMP-1	B-protein
antibodies	I-protein
,	O
demonstrating	O
that	O
secreted	O
TIMP-1	B-protein
is	O
active	O
in	O
blocking	O
apoptosis	O
.	O

Furthermore	O
,	O
TIMP-1	B-protein
upregulation	O
induced	O
expression	O
of	O
Bcl-XL	B-protein
but	O
not	O
Bcl-2	B-protein
as	O
well	O
as	O
decreased	O
NF-kappaB	B-protein
activity	O
as	O
compared	O
with	O
controls	O
.	O

These	O
results	O
demonstrate	O
that	O
TIMP-1	B-protein
suppresses	O
apoptosis	O
in	O
B	B-cell_type
cells	I-cell_type
and	O
suggests	O
a	O
novel	O
activity	O
for	O
TIMP-1	B-protein
in	O
tissue	O
homeostasis	O
.	O

In	NULL
Vitro	NULL
Suppression	NULL
of	NULL
Programmed	NULL
Cell	NULL
Death	NULL
of	NULL
B	NULL
Cells	NULL
by	NULL
Tissue	NULL
Inhibitor	NULL
of	NULL
Metalloproteinases-1	NULL
Liliana	NULL
Guedez	NULL
,	NULL
*	NULL
William	NULL
G.	NULL
Stetler-Stevenson	NULL
,	NULL
t	NULL
Linda	NULL
Wolff	NULL
,	NULL
§	NULL
Jiun	NULL
Wang	NULL
,	NULL
*	NULL
Paula	NULL
Fukushima	NULL
,	NULL
*	NULL
Adnan	NULL
Mansoor	NULL
,	NULL
*	NULL
and	NULL
Maryalice	NULL
Stetler-Stevenson*	NULL
*Flow	NULL
Cytometry	NULL
Unit	NULL
,	NULL
Hematopathology	NULL
Section	NULL
and	NULL
*Extracellular	NULL
Matrix	NULL
Pathology	NULL
Section	NULL
,	NULL
Laboratory	NULL
of	NULL
Pathology	NULL
,	NULL
Division	NULL
of	NULL
Clinical	NULL
Sciences	NULL
,	NULL
and	NULL
§Laboratory	NULL
of	NULL
Cellular	NULL
Oncology	NULL
,	NULL
Division	NULL
of	NULL
Basic	NULL
Sciences	NULL
,	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
Bethesda	NULL
,	NULL
Maryland	NULL
20892-1500	NULL
Abstract	NULL
Cellular	NULL
pathways	NULL
for	NULL
induction	NULL
of	NULL
programmed	NULL
cell	NULL
death	NULL
(	NULL
PCD	NULL
)	NULL
have	NULL
been	NULL
identified	NULL
,	NULL
but	NULL
little	NULL
is	NULL
known	NULL
about	NULL
specific	NULL
extracellular	NULL
matrix	NULL
processes	NULL
that	NULL
may	NULL
affect	NULL
apoptosis	NULL
along	NULL
those	NULL
pathways	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
a	NULL
series	NULL
of	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
(	NULL
BL	NULL
)	NULL
cell	NULL
lines	NULL
were	NULL
assayed	NULL
for	NULL
their	NULL
expression	NULL
of	NULL
tissue	NULL
inhibitor	NULL
of	NULL
metalloproteinases	NULL
(	NULL
TIMP	NULL
)	NULL
-1	NULL
.	NULL

Results	NULL
indicate	NULL
that	NULL
TIMP-1-positive	NULL
BL	NULL
lines	NULL
show	NULL
resistance	NULL
to	NULL
cold-shock-induced	NULL
apoptosis	NULL
.	NULL

Furthermore	NULL
,	NULL
recombinant	NULL
TIMP-1	NULL
,	NULL
but	NULL
not	NULL
TIMP-2	NULL
or	NULL
a	NULL
synthetic	NULL
metalloproteinase	NULL
inhibitor	NULL
(	NULL
BB-94	NULL
)	NULL
,	NULL
confers	NULL
resistance	NULL
to	NULL
apoptosis	NULL
induced	NULL
by	NULL
both	NULL
CD95-dependent	NULL
and	NULL
-independent	NULL
(	NULL
cold	NULL
shock	NULL
,	NULL
serum	NULL
deprivation	NULL
,	NULL
and	NULL
y-radiation	NULL
)	NULL
pathways	NULL
in	NULL
TIMP-1-negative	NULL
BL	NULL
lines	NULL
.	NULL

TIMP-1	NULL
suppression	NULL
of	NULL
PCD	NULL
is	NULL
not	NULL
due	NULL
to	NULL
metalloproteinase	NULL
inhibition	NULL
,	NULL
as	NULL
reduction	NULL
and	NULL
alkylation	NULL
of	NULL
the	NULL
TIMP-1	NULL
did	NULL
not	NULL
abolish	NULL
this	NULL
activity	NULL
.	NULL

Retroviral	NULL
induction	NULL
of	NULL
TIMP-1	NULL
not	NULL
only	NULL
resulted	NULL
in	NULL
cell	NULL
survival	NULL
but	NULL
also	NULL
in	NULL
continued	NULL
DNA	NULL
synthesis	NULL
for	NULL
up	NULL
to	NULL
5	NULL
d	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
serum	NULL
,	NULL
while	NULL
controls	NULL
underwent	NULL
apoptosis	NULL
.	NULL

This	NULL
resistance	NULL
to	NULL
apoptosis	NULL
is	NULL
reversed	NULL
by	NULL
anti-TIMP-1	NULL
antibodies	NULL
,	NULL
demonstrating	NULL
that	NULL
secreted	NULL
TIMP-1	NULL
is	NULL
active	NULL
in	NULL
blocking	NULL
apoptosis	NULL
.	NULL

Furthermore	NULL
,	NULL
TIMP-1	NULL
upregulation	NULL
induced	NULL
expression	NULL
of	NULL
Bel-X	NULL
;	NULL
,	NULL
but	NULL
not	NULL
Bcl-2	NULL
as	NULL
well	NULL
as	NULL
decreased	NULL
NF-KB	NULL
activity	NULL
as	NULL
compared	NULL
with	NULL
controls	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
TIMP-1	NULL
suppresses	NULL
apoptosis	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
suggests	NULL
a	NULL
novel	NULL
activity	NULL
for	NULL
TIMP-1	NULL
in	NULL
tissue	NULL
homeostasis	NULL
.	NULL

(	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

1998	NULL
.	NULL

102:2002-2010	NULL
.	NULL
)	NULL

Key	NULL
words	NULL
:	NULL
Bcel-X	NULL
-	NULL
Bel-2	NULL
«	NULL
extracellular	NULL
matrix	NULL
«	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
«	NULL
metalloproteinases	NULL
Introduction	NULL
Programmed	NULL
cell	NULL
death	NULL
(	NULL
PCD	NULL
)	NULL
,	NULL
or	NULL
apoptosis	NULL
,	NULL
is	NULL
now	NULL
recognized	NULL
as	NULL
playing	NULL
a	NULL
central	NULL
role	NULL
in	NULL
development	NULL
and	NULL
tissue-specific	NULL
functions	NULL
in	NULL
such	NULL
diverse	NULL
processes	NULL
as	NULL
regulation	NULL
of	NULL
immune	NULL
responses	NULL
,	NULL
angiogenesis	NULL
,	NULL
and	NULL
organogenesis	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

Address	NULL
correspondence	NULL
to	NULL
M.	NULL
Stetler-Stevenson	NULL
,	NULL
Flow	NULL
Cytometry	NULL
Unit	NULL
,	NULL
Hematopathology	NULL
Section	NULL
,	NULL
Laboratory	NULL
of	NULL
Pathology	NULL
,	NULL
DCS	NULL
,	NULL
NCI	NULL
,	NULL
Bldg	NULL
.	NULL

10	NULL
,	NULL
Room	NULL
2A33	NULL
,	NULL
MSC	NULL
#	NULL
1500	NULL
,	NULL
10	NULL
Center	NULL
Drive	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892-1500	NULL
.	NULL

Phone	NULL
:	NULL
301-402-1424	NULL
;	NULL
FAX	NULL
:	NULL
301-402-0043	NULL
;	NULL
E-mail	NULL
:	NULL
stetler	NULL
@	NULL
box-s.nih.gov	NULL
Received	NULL
for	NULL
publication	NULL
22	NULL
January	NULL
1998	NULL
and	NULL
accepted	NULL
in	NULL
revised	NULL
form	NULL
11	NULL
October	NULL
1998	NULL
.	NULL

1	NULL
.	NULL

Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
BRDU	NULL
,	NULL
bromodeoxyuridine	NULL
;	NULL
ECM	NULL
,	NULL
extracellular	NULL
matrix	NULL
;	NULL
MMP	NULL
,	NULL
matrix	NULL
metalloproteinase	NULL
;	NULL
PCD	NULL
,	NULL
programmed	NULL
cell	NULL
death	NULL
;	NULL
PI	NULL
,	NULL
propidium	NULL
iodide	NULL
;	NULL
TIMP	NULL
,	NULL
tissue	NULL
inhibitor	NULL
of	NULL
metalloproteinases	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Clinical	NULL
Investigation	NULL
Volume	NULL
102	NULL
,	NULL
Number	NULL
11	NULL
,	NULL
December	NULL
1998	NULL
,	NULL
2002-2010	NULL
http	NULL
:	NULL
//www.jci.org	NULL
2002	NULL
Guedez	NULL
et	NULL
al	NULL
.	NULL

In	NULL
these	NULL
processes	NULL
,	NULL
components	NULL
of	NULL
the	NULL
extracellular	NULL
matrix	NULL
(	NULL
ECM	NULL
)	NULL
(	NULL
4	NULL
)	NULL
and	NULL
in	NULL
particular	NULL
basement	NULL
membrane	NULL
act	NULL
as	NULL
survival	NULL
factors	NULL
and	NULL
suppress	NULL
apoptosis	NULL
.	NULL

Proteolytic	NULL
modification	NULL
of	NULL
matrix	NULL
organization	NULL
or	NULL
disruption	NULL
of	NULL
cell-matrix	NULL
contacts	NULL
can	NULL
result	NULL
in	NULL
initiation	NULL
of	NULL
PCD	NULL
in	NULL
epithelial	NULL
cells	NULL
,	NULL
with	NULL
induction	NULL
of	NULL
specific	NULL
molecular	NULL
effectors	NULL
of	NULL
apoptosis	NULL
such	NULL
as	NULL
caspases	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
it	NULL
was	NULL
shown	NULL
that	NULL
proteolytic	NULL
processing	NULL
of	NULL
TNF-	NULL
«	NULL
and	NULL
FAS	NULL
ligand	NULL
(	NULL
FasL	NULL
)	NULL
from	NULL
the	NULL
surface	NULL
of	NULL
lymphoid	NULL
cells	NULL
by	NULL
matrix	NULL
metalloproteinase-like	NULL
activity	NULL
can	NULL
also	NULL
alter	NULL
PCD	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
examined	NULL
the	NULL
expression	NULL
of	NULL
matrix	NULL
metalloproteinases	NULL
(	NULL
MMPs	NULL
)	NULL
and	NULL
their	NULL
endogenous	NULL
inhibi-tors	NULL
,	NULL
the	NULL
tissue	NULL
inhibitors	NULL
of	NULL
metalloproteinases	NULL
(	NULL
TIMPs	NULL
)	NULL
,	NULL
in	NULL
human	NULL
normal	NULL
and	NULL
neoplastic	NULL
lymphoid	NULL
cell	NULL
lines	NULL
(	NULL
7	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
TIMP-1	NULL
secretion	NULL
was	NULL
shown	NULL
only	NULL
by	NULL
normal	NULL
activated	NULL
tonsillar	NULL
B	NULL
cells	NULL
and	NULL
by	NULL
a	NULL
subset	NULL
of	NULL
high-grade	NULL
Burkitt	NULL
's	NULL
lymphomas	NULL
but	NULL
not	NULL
by	NULL
quiescent	NULL
peripheral	NULL
blood	NULL
cells	NULL
or	NULL
follicu-lar	NULL
lymphoma	NULL
cell	NULL
lines	NULL
.	NULL

MMP	NULL
expression	NULL
was	NULL
variable	NULL
and	NULL
did	NULL
not	NULL
correlate	NULL
with	NULL
TIMP-1	NULL
production	NULL
.	NULL

These	NULL
results	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
previous	NULL
reports	NULL
from	NULL
our	NULL
laboratory	NULL
and	NULL
others	NULL
that	NULL
TIMP-1	NULL
expression	NULL
correlates	NULL
with	NULL
clinical	NULL
grade	NULL
in	NULL
non-Hodgkin	NULL
's	NULL
lymphomas	NULL
as	NULL
well	NULL
as	NULL
in	NULL
other	NULL
malignancies	NULL
but	NULL
did	NULL
not	NULL
correlate	NULL
with	NULL
MMP	NULL
expression	NULL
(	NULL
8-10	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
these	NULL
effects	NULL
of	NULL
TIMPs	NULL
may	NULL
be	NULL
independent	NULL
of	NULL
their	NULL
ability	NULL
to	NULL
inhibit	NULL
MMPs	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
TIMP-1	NULL
promotes	NULL
survival	NULL
of	NULL
serum-dependent	NULL
cell	NULL
lines	NULL
,	NULL
including	NULL
Burkitt	NULL
's	NULL
lymphomas	NULL
,	NULL
in	NULL
serum-free	NULL
conditions	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
extracellular	NULL
matrix	NULL
proteases	NULL
or	NULL
their	NULL
inhibitors	NULL
(	NULL
TIMPs	NULL
)	NULL
may	NULL
directly	NULL
influence	NULL
malignancy	NULL
and	NULL
PCD	NULL
in	NULL
B	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
in	NULL
other	NULL
cell	NULL
types	NULL
.	NULL

The	NULL
present	NULL
study	NULL
was	NULL
therefore	NULL
undertaken	NULL
to	NULL
determine	NULL
whether	NULL
TIMP-1	NULL
regulates	NULL
apoptosis	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
of	NULL
our	NULL
study	NULL
demonstrate	NULL
that	NULL
TIMP-1	NULL
directly	NULL
controls	NULL
apoptosis	NULL
through	NULL
a	NULL
novel	NULL
,	NULL
non-MMP	NULL
inhibitory	NULL
pathway	NULL
and	NULL
suggest	NULL
that	NULL
this	NULL
protein	NULL
plays	NULL
a	NULL
pivotal	NULL
role	NULL
in	NULL
maintenance	NULL
of	NULL
B	NULL
cell	NULL
homeostasis	NULL
.	NULL

Methods	NULL
Cells	NULL
.	NULL

Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
lines	NULL
used	NULL
in	NULL
this	NULL
study	NULL
(	NULL
see	NULL
Table	NULL
I	NULL
)	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
Ian	NULL
Magrath	NULL
,	NULL
Chief	NULL
of	NULL
Lymphoma	NULL
Biology	NULL
Section	NULL
,	NULL
National	NULL
Cancer	NULL
Institute	NULL
(	NULL
NCT	NULL
)	NULL
(	NULL
14-17	NULL
)	NULL
or	NULL
purchased	NULL
from	NULL
ATCC	NULL
(	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Hyperplastic	NULL
tonsils	NULL
were	NULL
obtained	NULL
fresh	NULL
in	NULL
saline	NULL
.	NULL

A	NULL
cell	NULL
suspension	NULL
was	NULL
prepared	NULL
.	NULL

The	NULL
tonsillar	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
serum-free	NULL
conditions	NULL
overnight	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
400	NULL
ng/ml	NULL
of	NULL
rTIMP-1	NULL
.	NULL

Cell	NULL
lines	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
obtained	NULL
from	NULL
GIBCO	NULL
BRL	NULL
(	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
,	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FBS	NULL
(	NULL
without	NULL
serum	NULL
as	NULL
indicated	NULL
)	NULL
,	NULL
and	NULL
antibiotics	NULL
,	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
,	NULL
at	NULL
37°C	NULL
.	NULL

TIMP-1	NULL
specificity	NULL
.	NULL

JD38	NULL
cells	NULL
were	NULL
preincubated	NULL
with	NULL
both	NULL
native	NULL
recombinant	NULL
TIMP-1	NULL
and	NULL
reduced	NULL
and	NULL
alkylated	NULL
TIMP-1	NULL
(	NULL
50-250	NULL
ng/ml	NULL
)	NULL
,	NULL
recombinant	NULL
TIMP-2	NULL
(	NULL
250-500	NULL
ng/ml	NULL
)	NULL
,	NULL
and	NULL
the	NULL
synthetic	NULL
MMP	NULL
inhibitor	NULL
BB-94	NULL
(	NULL
5	NULL
wM	NULL
)	NULL
obtained	NULL
from	NULL
British	NULL
Biotech	NULL
(	NULL
Ox-ford	NULL
,	NULL
England	NULL
)	NULL
for	NULL
24	NULL
h	NULL
before	NULL
induction	NULL
of	NULL
apoptosis	NULL
.	NULL

TIMP-1	NULL
dose	NULL
response	NULL
.	NULL

JD38	NULL
cells	NULL
(	NULL
2.5	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
a	NULL
96-well	NULL
plate	NULL
with	NULL
serum-free	NULL
media	NULL
and	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
rTIMP-1	NULL
(	NULL
1.43-143	NULL
nM	NULL
)	NULL
prepared	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
18	NULL
)	NULL
.	NULL

After	NULL
48	NULL
h	NULL
,	NULL
the	NULL
number	NULL
of	NULL
viable	NULL
cells	NULL
was	NULL
determined	NULL
.	NULL

Apoptosis-inducing	NULL
treatments	NULL
.	NULL

In	NULL
all	NULL
methods	NULL
,	NULL
cells	NULL
were	NULL
monitored	NULL
for	NULL
apoptosis	NULL
over	NULL
extended	NULL
periods	NULL
of	NULL
time	NULL
(	NULL
4-72	NULL
h	NULL
)	NULL
,	NULL
and	NULL
optimal	NULL
time	NULL
points	NULL
for	NULL
detection	NULL
of	NULL
apoptosis	NULL
were	NULL
determined	NULL
.	NULL

Cold-shock	NULL
induction	NULL
of	NULL
apoptosis	NULL
was	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
19	NULL
)	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
1	NULL
X	NULL
10°	NULL
cells/ml	NULL
were	NULL
incubated	NULL
at	NULL
4°C	NULL
for	NULL
4	NULL
h	NULL
and	NULL
returned	NULL
to	NULL
37°C	NULL
for	NULL
an	NULL
additional	NULL
4-8	NULL
h.	NULL
Anti-Fas	NULL
apoptosis	NULL
was	NULL
induced	NULL
as	NULL
follows	NULL
:	NULL
2	NULL
X	NULL
10°	NULL
cells/ml	NULL
were	NULL
treated	NULL
for	NULL
6-24	NULL
h	NULL
with	NULL
200	NULL
ng/ml	NULL
anti-CD95	NULL
monoclonal	NULL
antibody	NULL
clone	NULL
CH-11	NULL
purchased	NULL
from	NULL
Immuno-tech	NULL
(	NULL
Miami	NULL
,	NULL
FL	NULL
)	NULL
at	NULL
37°C	NULL
.	NULL

For	NULL
serum	NULL
deprivation	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
48	NULL
h	NULL
in	NULL
serum-free	NULL
RPMI	NULL
at	NULL
37°C	NULL
.	NULL

Cells	NULL
were	NULL
also	NULL
treated	NULL
with	NULL
800	NULL
rads	NULL
using	NULL
a	NULL
Gamma	NULL
Cell	NULL
40	NULL
irradiator	NULL
,	NULL
followed	NULL
by	NULL
incubation	NULL
in	NULL
fresh	NULL
RPMI	NULL
at	NULL
37°C	NULL
.	NULL

Apoptosis	NULL
was	NULL
also	NULL
induced	NULL
in	NULL
TIMP-1	NULL
positive	NULL
cells	NULL
grown	NULL
in	NULL
serum-free	NULL
media	NULL
and	NULL
with	NULL
anti-TIMP-1	NULL
monoclonal	NULL
antibody	NULL
(	NULL
5	NULL
pg/ml	NULL
)	NULL
.	NULL

Anti-TIMP-2	NULL
and	NULL
irrelevant	NULL
isotype	NULL
were	NULL
used	NULL
as	NULL
controls	NULL
.	NULL

The	NULL
TIMP-1	NULL
and	NULL
TIMP-2	NULL
antibodies	NULL
were	NULL
purchased	NULL
from	NULL
Oncogene	NULL
Research	NULL
Products	NULL
(	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Detection	NULL
of	NULL
apoptosis	NULL
.	NULL

Apoptosis	NULL
was	NULL
measured	NULL
by	NULL
at	NULL
least	NULL
three	NULL
methods	NULL
for	NULL
each	NULL
condition	NULL
.	NULL

All	NULL
cells	NULL
were	NULL
reviewed	NULL
microscopically	NULL
for	NULL
morphological	NULL
evidence	NULL
of	NULL
apoptosis	NULL
such	NULL
as	NULL
blebbing	NULL
and	NULL
nuclear	NULL
condensation	NULL
.	NULL

Apoptosis	NULL
was	NULL
detected	NULL
using	NULL
flow	NULL
cytometry	NULL
by	NULL
the	NULL
following	NULL
methods	NULL
:	NULL
light	NULL
scatter	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
20	NULL
)	NULL
and	NULL
decreased	NULL
DNA	NULL
content	NULL
by	NULL
using	NULL
propidium	NULL
iodide	NULL
(	NULL
PT	NULL
)	NULL
staining	NULL
(	NULL
sub-diploid	NULL
peak	NULL
characteristic	NULL
of	NULL
DNA	NULL
fragmentation	NULL
)	NULL
,	NULL
Annexin	NULL
V	NULL
stain-ing	NULL
,	NULL
assay	NULL
of	NULL
Caspase-3	NULL
activity	NULL
,	NULL
and	NULL
TUNEL	NULL
method	NULL
(	NULL
detects	NULL
TdT	NULL
incorporation	NULL
of	NULL
labeled	NULL
nucleotides	NULL
into	NULL
DNA	NULL
strand	NULL
breaks	NULL
)	NULL
.	NULL

DNA	NULL
content	NULL
analysis	NULL
by	NULL
PI	NULL
staining	NULL
and	NULL
the	NULL
TUNEL	NULL
method	NULL
were	NULL
combined	NULL
using	NULL
the	NULL
Fluorescein	NULL
Cell	NULL
Death	NULL
Detection	NULL
Kit	NULL
in	NULL
a	NULL
modification	NULL
of	NULL
the	NULL
manufacturer	NULL
's	NULL
protocol	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
India-napolis	NULL
,	NULL
IN	NULL
)	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
2	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
PBS	NULL
with	NULL
1	NULL
%	NULL
BSA	NULL
and	NULL
fixed	NULL
in	NULL
2	NULL
%	NULL
paraformaldehyde	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
tempera-ture	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
,	NULL
permeabilized	NULL
with	NULL
0.1	NULL
%	NULL
Triton-X	NULL
100	NULL
and	NULL
2	NULL
%	NULL
SSC	NULL
for	NULL
2	NULL
min	NULL
on	NULL
ice	NULL
and	NULL
resuspended	NULL
in	NULL
50	NULL
wL	NULL
of	NULL
TUNEL	NULL
reaction	NULL
media	NULL
from	NULL
the	NULL
Boehringer	NULL
's	NULL
kit	NULL
.	NULL

After	NULL
1	NULL
h	NULL
incubation	NULL
at	NULL
37°C	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
PBS	NULL
and	NULL
resuspended	NULL
in	NULL
1	NULL
ml	NULL
(	NULL
5	NULL
mg/ml	NULL
!	NULL
)	NULL

PI	NULL
from	NULL
Calbiochem	NULL
(	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
1	NULL
pl	NULL
of	NULL
5	NULL
mg/ml	NULL
Ribonuclease	NULL
A	NULL
from	NULL
Worthington	NULL
Biochemical	NULL
(	NULL
Freehold	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

Apoptosis	NULL
was	NULL
detected	NULL
in	NULL
tonsillar	NULL
cells	NULL
by	NULL
using	NULL
Annexin	NULL
V-FITC	NULL
from	NULL
Caltag	NULL
(	NULL
Burlingame	NULL
,	NULL
CA	NULL
)	NULL
in	NULL
conjunction	NULL
with	NULL
PE-anti-CD3	NULL
antibody	NULL
(	NULL
T	NULL
cells	NULL
)	NULL
,	NULL
anti-CD10	NULL
antibody	NULL
(	NULL
germinal	NULL
center	NULL
B	NULL
cells	NULL
)	NULL
obtained	NULL
from	NULL
Dako	NULL
(	NULL
Carpinteria	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
PerCP-anti-CD20	NULL
antibody	NULL
from	NULL
Becton	NULL
Dickinson	NULL
(	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
caspase-3	NULL
was	NULL
detected	NULL
by	NULL
using	NULL
fluorogenic	NULL
substrate	NULL
PhiPhilux	NULL
obtained	NULL
from	NULL
Oncolmmu-nin	NULL
(	NULL
College	NULL
Park	NULL
,	NULL
MD	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
protocol	NULL
.	NULL

Flow	NULL
cytometric	NULL
analysis	NULL
was	NULL
done	NULL
on	NULL
a	NULL
FACScan®	NULL
from	NULL
Becton	NULL
Dickinson	NULL
(	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

TIMP-1	NULL
retroviral	NULL
construct	NULL
.	NULL

The	NULL
TIMP-l-negative	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
line	NULL
JD-38	NULL
was	NULL
selected	NULL
,	NULL
and	NULL
LXSN	NULL
retroviral	NULL
transduction	NULL
was	NULL
used	NULL
to	NULL
induce	NULL
TIMP-1	NULL
expression	NULL
.	NULL

JD-38	NULL
cells	NULL
(	NULL
see	NULL
Table	NULL
I	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
Dr.	NULL
Ian	NULL
Magrath	NULL
(	NULL
Lymphoma	NULL
Biology	NULL
Section	NULL
,	NULL
NCI	NULL
)	NULL
.	NULL

TIMP-1	NULL
cDNA	NULL
was	NULL
obtained	NULL
by	NULL
PCR	NULL
and	NULL
subcloned	NULL
into	NULL
LXSN	NULL
by	NULL
using	NULL
DNA	NULL
recombinant	NULL
techniques	NULL
.	NULL

Empty	NULL
LXSN	NULL
or	NULL
TIMP-1-LXSN	NULL
constructs	NULL
were	NULL
transfected	NULL
into	NULL
packaging	NULL
lines	NULL
.	NULL

Nonadherent	NULL
JD38	NULL
cells	NULL
were	NULL
then	NULL
cocultured	NULL
with	NULL
adherent	NULL
LXSN-TIMP-1	NULL
packaging	NULL
cells	NULL
(	NULL
GP+envAM1I2	NULL
)	NULL
for	NULL
48	NULL
h	NULL
(	NULL
21	NULL
)	NULL
.	NULL

LXSN	NULL
TIMP-1-infected	NULL
JD38	NULL
cells	NULL
were	NULL
then	NULL
selected	NULL
using	NULL
2,500	NULL
pg/ml	NULL
G418	NULL
for	NULL
10	NULL
d.	NULL
Individual	NULL
clones	NULL
were	NULL
isolated	NULL
by	NULL
repeated	NULL
limiting	NULL
dilution	NULL
.	NULL

Clonality	NULL
was	NULL
confirmed	NULL
by	NULL
restriction	NULL
enzyme	NULL
digestion	NULL
with	NULL
Sma	NULL
I	NULL
and	NULL
Southern	NULL
blot	NULL
analysis	NULL
,	NULL
with	NULL
unique	NULL
sites	NULL
of	NULL
integration	NULL
detected	NULL
in	NULL
the	NULL
JD38	NULL
cell	NULL
clones	NULL
used	NULL
in	NULL
this	NULL
study	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
.	NULL

Total	NULL
RNA	NULL
(	NULL
7.5	NULL
ug	NULL
)	NULL
,	NULL
extracted	NULL
from	NULL
cell	NULL
suspensions	NULL
by	NULL
using	NULL
RNAzol	NULL
purchased	NULL
from	NULL
Cinna/Biotecx	NULL
Laboratories	NULL
(	NULL
Houston	NULL
,	NULL
TX	NULL
)	NULL
was	NULL
electrophoresed	NULL
on	NULL
1	NULL
%	NULL
wt/vol	NULL
agarose-formaldehyde	NULL
gel	NULL
before	NULL
transfer	NULL
onto	NULL
nylon	NULL
filters	NULL
GeneScreen	NULL
Plus	NULL
from	NULL
Dupont	NULL
,	NULL
NEN	NULL
products	NULL
(	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
and	NULL
ultraviolet	NULL
(	NULL
UV	NULL
)	NULL
cross-linking	NULL
to	NULL
the	NULL
filter	NULL
.	NULL

Blots	NULL
were	NULL
hybridized	NULL
using	NULL
standard	NULL
conditions	NULL
with	NULL
TIMP-1	NULL
and	NULL
GAPDH	NULL
probes	NULL
labeled	NULL
with	NULL
a	NULL
[	NULL
P	NULL
]	NULL
dCTP	NULL
by	NULL
using	NULL
a	NULL
random	NULL
primer	NULL
labeling	NULL
kit	NULL
from	NULL
Bethesda	NULL
Research	NULL
Laboratories	NULL
(	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
.	NULL

Conditioned	NULL
media	NULL
was	NULL
collected	NULL
from	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
lines	NULL
after	NULL
48	NULL
h	NULL
incubation	NULL
of	NULL
3	NULL
X	NULL
10°	NULL
cells/ml	NULL
at	NULL
37°C	NULL
and	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
,	NULL
in	NULL
AIMV	NULL
or	NULL
serum-free	NULL
RPMI	NULL
media	NULL
both	NULL
purchased	NULL
from	NULL
GIBCO	NULL
BRL	NULL
(	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Supernatants	NULL
were	NULL
cleared	NULL
of	NULL
cells	NULL
by	NULL
centrifugation	NULL
and	NULL
protein	NULL
concentration	NULL
determined	NULL
by	NULL
BCA	NULL
protein	NULL
assay	NULL
from	NULL
Pierce	NULL
(	NULL
Rockford	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
proteins	NULL
in	NULL
20-40	NULL
pL	NULL
of	NULL
conditioned	NULL
media	NULL
were	NULL
electrophoresed	NULL
in	NULL
a	NULL
4-20	NULL
%	NULL
(	NULL
wt/vol	NULL
)	NULL
,	NULL
polyacrylamide/SDS	NULL
gel	NULL
at	NULL
100	NULL
V	NULL
for	NULL
60	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
electroblotted	NULL
onto	NULL
polyvinylidine	NULL
difluoride	NULL
membranes	NULL
from	NULL
Novex	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
at	NULL
10	NULL
V	NULL
for	NULL
25	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
by	NULL
using	NULL
a	NULL
semidry	NULL
BIO-RAD	NULL
electro-blotter	NULL
(	NULL
Indianapolis	NULL
,	NULL
IN	NULL
)	NULL
.	NULL

Rabbit	NULL
polyclonal	NULL
antibodies	NULL
against	NULL
TIMP-1	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
Bente	NULL
Birkedahl-Hansen	NULL
(	NULL
Extracellu-lar	NULL
Matrix	NULL
Pathology	NULL
Section	NULL
,	NULL
Laboratory	NULL
of	NULL
Pathology	NULL
,	NULL
NCI	NULL
)	NULL
and	NULL
murine	NULL
monoclonal	NULL
TIMP-1	NULL
antibody	NULL
purchased	NULL
from	NULL
Oncogene	NULL
Sciences	NULL
(	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
;	NULL
dilutions	NULL
of	NULL
1:1,000	NULL
were	NULL
used	NULL
.	NULL

Also	NULL
,	NULL
cytoplas-matic	NULL
proteins	NULL
were	NULL
extracted	NULL
using	NULL
RIPA	NULL
buffer	NULL
(	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
%	NULL
NP-40	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
,	NULL
50	NULL
mM	NULL
Tris-HCL	NULL
,	NULL
pH	NULL
8.0	NULL
)	NULL
containing	NULL
protease	NULL
inhibitors	NULL
from	NULL
JD38	NULL
cells	NULL
,	NULL
LXSN-JD38	NULL
cells	NULL
and	NULL
TIMP-1-JD38	NULL
cells	NULL
,	NULL
and	NULL
50	NULL
pg	NULL
of	NULL
proteins	NULL
fractionated	NULL
by	NULL
electrophoresis	NULL
as	NULL
explained	NULL
previously	NULL
.	NULL

Antibodies	NULL
against	NULL
Bel-2	NULL
,	NULL
Bel-X	NULL
;	NULL
s	NULL
,	NULL
p-65	NULL
NFB	NULL
,	NULL
and	NULL
IxBa	NULL
were	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
used	NULL
.	NULL

These	NULL
blots	NULL
were	NULL
developed	NULL
with	NULL
a	NULL
horseradish	NULL
peroxidase-conjugated	NULL
goat	NULL
anti-rabbit	NULL
immunoglobulin	NULL
or	NULL
goat	NULL
anti-mouse	NULL
both	NULL
from	NULL
Pierce	NULL
and	NULL
a	NULL
chemiluminesence	NULL
kit	NULL
from	NULL
DuPont	NULL
,	NULL
NEN	NULL
.	NULL

Cell	NULL
cycle	NULL
and	NULL
DNA	NULL
synthesis	NULL
.	NULL

TIMP-1-JD38	NULL
cell	NULL
clones	NULL
and	NULL
LXSN-JD38	NULL
cells	NULL
(	NULL
5	NULL
X	NULL
10	NULL
%	NULL
/ml	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
serum	NULL
for	NULL
1-5	NULL
d.	NULL
10	NULL
M	NULL
bromodeoxyuridine	NULL
(	NULL
BRDU	NULL
)	NULL
from	NULL
Calbiochem	NULL
(	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
was	NULL
added	NULL
30	NULL
min	NULL
before	NULL
harvesting	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
rinsed	NULL
in	NULL
PBS	NULL
and	NULL
fixed	NULL
with	NULL
1	NULL
%	NULL
paraformaldehyde	NULL
,	NULL
followed	NULL
by	NULL
treatment	NULL
with	NULL
cold	NULL
ethanol	NULL
,	NULL
and	NULL
2	NULL
N	NULL
HCL	NULL
.	NULL

Cell	NULL
suspension	NULL
pH	NULL
was	NULL
normalized	NULL
with	NULL
borate	NULL
buffer	NULL
(	NULL
pH	NULL
8.9	NULL
)	NULL
.	NULL

After	NULL
rinsing	NULL
with	NULL
PBS	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
FITC	NULL
mouse	NULL
anti-BRDU	NULL
antibody	NULL
from	NULL
Becton-Dickinson	NULL
,	NULL
30	NULL
min	NULL
on	NULL
ice	NULL
,	NULL
in	NULL
the	NULL
dark	NULL
.	NULL

Total	NULL
DNA	NULL
was	NULL
counterstained	NULL
with	NULL
solution	NULL
containing	NULL
50	NULL
pg/ml	NULL
propidium	NULL
iodine	NULL
from	NULL
Calbiochem	NULL
and	NULL
1	NULL
pl	NULL
Ribonuclease	NULL
A	NULL
(	NULL
5	NULL
mg/m	NULL
!	NULL

l	NULL
)	NULL
from	NULL
Worthington	NULL
Biochemical	NULL
.	NULL

Cell	NULL
cycle	NULL
distribution	NULL
determined	NULL
by	NULL
PI	NULL
staining	NULL
and	NULL
DNA	NULL
synthesis	NULL
detected	NULL
by	NULL
BRDU	NULL
uptake	NULL
were	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
using	NULL
a	NULL
Becton-Dickinson	NULL
FACScan®	NULL
and	NULL
CellQuest	NULL
software	NULL
.	NULL

Results	NULL
TIMP-1	NULL
expression	NULL
and	NULL
apoptosis	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
soluble	NULL
components	NULL
of	NULL
the	NULL
ECM	NULL
such	NULL
as	NULL
MMPs	NULL
and	NULL
their	NULL
inhibitors	NULL
regulate	NULL
apoptosis	NULL
in	NULL
nonadhesion-dependent	NULL
fashion	NULL
,	NULL
we	NULL
correlated	NULL
the	NULL
expression	NULL
of	NULL
these	NULL
components	NULL
with	NULL
the	NULL
response	NULL
of	NULL
a	NULL
series	NULL
of	NULL
human	NULL
,	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
lines	NULL
to	NULL
cold-shock-induced	NULL
apoptosis	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

Apoptosis	NULL
was	NULL
determined	NULL
by	NULL
morphology	NULL
and	NULL
flow	NULL
cytometry	NULL
as	NULL
explained	NULL
in	NULL
Methods	NULL
.	NULL

TIMP-1	NULL
expression	NULL
in	NULL
these	NULL
Burkitt	NULL
's	NULL
cell	NULL
lines	NULL
,	NULL
determined	NULL
by	NULL
Northern	NULL
and	NULL
Western	NULL
blot	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
showed	NULL
100	NULL
%	NULL
correlation	NULL
with	NULL
resistance	NULL
to	NULL
cold-shock-induced	NULL
apoptosis	NULL
.	NULL

Four	NULL
of	NULL
the	NULL
nine	NULL
cell	NULL
lines	NULL
tested	NULL
are	NULL
TIMP-1	NULL
positive	NULL
and	NULL
did	NULL
not	NULL
undergo	NULL
induction	NULL
of	NULL
apoptosis	NULL
after	NULL
cold	NULL
shock	NULL
while	NULL
cell	NULL
lines	NULL
readily	NULL
underwent	NULL
apoptosis	NULL
.	NULL

This	NULL
response	NULL
was	NULL
not	NULL
associated	NULL
with	NULL
other	NULL
markers	NULL
of	NULL
biologic	NULL
behavior	NULL
that	NULL
have	NULL
been	NULL
well	NULL
studied	NULL
in	NULL
these	NULL
and	NULL
other	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
lines	NULL
such	NULL
as	NULL
patient	NULL
origin	NULL
,	NULL
chromosomal	NULL
translocation	NULL
(	NULL
t	NULL
(	NULL
8	NULL
;	NULL
14	NULL
)	NULL
vs.	NULL
t	NULL
(	NULL
8	NULL
;	NULL
22	NULL
)	NULL
)	NULL
,	NULL
presence	NULL
of	NULL
p53	NULL
mutation	NULL
,	NULL
or	NULL
level	NULL
of	NULL
e-mye	NULL
expression	NULL
(	NULL
14-17	NULL
)	NULL
.	NULL

Although	NULL
all	NULL
TIMP-1-positive	NULL
lines	NULL
were	NULL
infected	NULL
with	NULL
EBV	NULL
,	NULL
both	NULL
EBV-positive	NULL
and	NULL
negative	NULL
lines	NULL
were	NULL
TIMP-1	NULL
negative	NULL
.	NULL

Some	NULL
of	NULL
the	NULL
Burkitt	NULL
's	NULL
cell	NULL
lines	NULL
studied	NULL
expressed	NULL
MMP-9	NULL
as	NULL
assayed	NULL
by	NULL
zy-	NULL
TIMP-1	NULL
Suppression	NULL
of	NULL
Programmed	NULL
Cell	NULL
Death	NULL
in	NULL
B	NULL
Cells	NULL
_	NULL
2003	NULL
Table	NULL
I	NULL
.	NULL

Correlation	NULL
of	NULL
Burkitt	NULL
's	NULL
Lymphoma	NULL
Cell	NULL
Line	NULL
Phenotype	NULL
with	NULL
Susceptibility	NULL
to	NULL
Programmed	NULL
Cell	NULL
Death	NULL
Cell	NULL
line	NULL
Origin/translocation	NULL
EBV	NULL
p53	NULL
TIMP-1*	NULL
GelB	NULL
Apoptosis	NULL
PA682	NULL
American	NULL
[	NULL
t	NULL
(	NULL
8	NULL
;	NULL
22	NULL
)	NULL
]	NULL
_+	NULL
+	NULL
+	NULL
+	NULL
AG876	NULL
-	NULL
African	NULL
[	NULL
t	NULL
(	NULL
8	NULL
;	NULL
14	NULL
)	NULL
]	NULL
+	NULL
-	NULL
+	NULL
-	NULL
_	NULL
DW6	NULL
American	NULL
[	NULL
t	NULL
(	NULL
8	NULL
;	NULL
14	NULL
)	NULL
]	NULL
+	NULL
-	NULL
4	NULL
_	NULL
_	NULL
Jijyoe	NULL
_	NULL
African	NULL
[	NULL
t	NULL
(	NULL
8	NULL
;	NULL
14	NULL
)	NULL
]	NULL
+o	NULL
O+	NULL
+	NULL
+	NULL
_-Raji	NULL
African	NULL
[	NULL
t	NULL
(	NULL
8	NULL
;	NULL
14	NULL
)	NULL
]	NULL
+	NULL
+	NULL
a	NULL
4	NULL
4	NULL
JD38	NULL
American	NULL
[	NULL
t	NULL
(	NULL
8	NULL
;	NULL
14	NULL
)	NULL
]	NULL
-	NULL
+	NULL
_	NULL
4	NULL
4	NULL
Daudi	NULL
__	NULL
African	NULL
[	NULL
t	NULL
(	NULL
8	NULL
;	NULL
14	NULL
)	NULL
]	NULL
+	NULL
+	NULL
-	NULL
-	NULL
4	NULL
EW36	NULL
_-	NULL
American	NULL
[	NULL
t	NULL
(	NULL
8	NULL
;	NULL
14	NULL
)	NULL
]	NULL
-	NULL
-	NULL
_	NULL
_	NULL
4	NULL
ST46	NULL
American	NULL
[	NULL
t	NULL
(	NULL
8	NULL
;	NULL
14	NULL
)	NULL
]	NULL
-	NULL
+	NULL
_	NULL
_	NULL
4	NULL
Cell	NULL
lines	NULL
were	NULL
established	NULL
from	NULL
patients	NULL
with	NULL
malignant	NULL
lymphoma	NULL
and	NULL
small	NULL
noncleaved	NULL
,	NULL
Burkitt	NULL
's	NULL
subtype	NULL
,	NULL
and	NULL
include	NULL
African	NULL
and	NULL
American	NULL
Burkitt	NULL
's	NULL
as	NULL
well	NULL
as	NULL
cases	NULL
with	NULL
the	NULL
t	NULL
(	NULL
8	NULL
;	NULL
14	NULL
)	NULL
and	NULL
(	NULL
8:22	NULL
)	NULL
translocations	NULL
.	NULL

Origin	NULL
,	NULL
translocation	NULL
,	NULL
EBV	NULL
,	NULL
and	NULL
p53	NULL
mutation	NULL
data	NULL
provided	NULL
in	NULL
Methods	NULL
.	NULL

*TIMP-1	NULL
expression	NULL
determined	NULL
by	NULL
Northern	NULL
and	NULL
Western	NULL
blot	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Gelatinase	NULL
B	NULL
expression	NULL
was	NULL
determined	NULL
by	NULL
zymography	NULL
as	NULL
previously	NULL
reported	NULL
.	NULL

Apoptosis	NULL
was	NULL
induced	NULL
by	NULL
cold	NULL
shock	NULL
and	NULL
detected	NULL
by	NULL
examination	NULL
of	NULL
morphology	NULL
in	NULL
culture	NULL
for	NULL
typical	NULL
apoptotic	NULL
changes	NULL
and	NULL
by	NULL
flow	NULL
cytometry	NULL
using	NULL
changes	NULL
in	NULL
light	NULL
scatter	NULL
characteristics	NULL
as	NULL
described	NULL
in	NULL
Methods	NULL
.	NULL

mography	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
but	NULL
secretion	NULL
of	NULL
this	NULL
MMP	NULL
is	NULL
not	NULL
related	NULL
with	NULL
susceptibility	NULL
to	NULL
PCD	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

In	NULL
most	NULL
lymphoid	NULL
cell	NULL
lines	NULL
,	NULL
PCD	NULL
is	NULL
induced	NULL
by	NULL
withdrawal	NULL
of	NULL
serum	NULL
growth	NULL
factors	NULL
.	NULL

The	NULL
fetal	NULL
bovine	NULL
serum	NULL
commonly	NULL
used	NULL
in	NULL
tissue	NULL
culture	NULL
is	NULL
a	NULL
source	NULL
of	NULL
TIMP-1	NULL
,	NULL
and	NULL
as	NULL
reported	NULL
by	NULL
Hayakawa	NULL
et	NULL
al	NULL
.	NULL

(	NULL
13	NULL
)	NULL
,	NULL
depletion	NULL
of	NULL
TIMP-1	NULL
from	NULL
the	NULL
serum	NULL
is	NULL
necessary	NULL
to	NULL
demonstrate	NULL
the	NULL
growth	NULL
effects	NULL
of	NULL
TIMP-1	NULL
in	NULL
several	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
line	NULL
AG876	NULL
expresses	NULL
high	NULL
levels	NULL
of	NULL
TIMP-1	NULL
and	NULL
is	NULL
resistant	NULL
to	NULL
induction	NULL
of	NULL
PCD	NULL
by	NULL
incubation	NULL
in	NULL
serum-free	NULL
media	NULL
.	NULL

Neutralization	NULL
of	NULL
secreted	NULL
TIMP-1	NULL
by	NULL
incubation	NULL
of	NULL
AG876	NULL
cells	NULL
with	NULL
anti-antibody	NULL
results	NULL
in	NULL
a	NULL
fourfold	NULL
increased	NULL
induction	NULL
of	NULL
apoptosis	NULL
under	NULL
serum-free	NULL
conditions	NULL
(	NULL
24.03+0.6	NULL
%	NULL
[	NULL
SD	NULL
]	NULL
apoptotic	NULL
AG876	NULL
cells	NULL
in	NULL
anti-TIMP-1-treated	NULL
compared	NULL
with	NULL
6.9+1.05	NULL
%	NULL
[	NULL
SD	NULL
]	NULL
apoptotic	NULL
AG876	NULL
cells	NULL
in	NULL
controls	NULL
,	NULL
determined	NULL
by	NULL
TUNEL/	NULL
PI	NULL
in	NULL
duplicate	NULL
determinations	NULL
of	NULL
two	NULL
experiments	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
resistance	NULL
to	NULL
apoptosis	NULL
is	NULL
associated	NULL
with	NULL
TIMP-1	NULL
expression	NULL
in	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
lines	NULL
.	NULL

No	NULL
other	NULL
biological	NULL
parameter	NULL
studied	NULL
in	NULL
these	NULL
tumors	NULL
shows	NULL
correlation	NULL
with	NULL
apoptosis	NULL
.	NULL

TIMP-1	NULL
protects	NULL
against	NULL
PCD	NULL
.	NULL

Recombinant	NULL
TIMP-1	NULL
inhibited	NULL
PCD	NULL
induced	NULL
by	NULL
serum	NULL
starvation	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
)	NULL
,	NULL
cold	NULL
shock	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
B	NULL
)	NULL
,	NULL
and	NULL
Fas	NULL
activation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
in	NULL
the	NULL
TIMP-1	NULL
nonexpressing	NULL
,	NULL
EBV-negative	NULL
JD38	NULL
cell	NULL
line	NULL
.	NULL

Cell	NULL
viability	NULL
in	NULL
serum	NULL
deprivation	NULL
was	NULL
dose	NULL
dependent	NULL
in	NULL
the	NULL
JD38	NULL
cells	NULL
incubated	NULL
with	NULL
1.4-143	NULL
nM	NULL
rTIMP-1	NULL
for	NULL
48	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
)	NULL
with	NULL
50	NULL
%	NULL
survival	NULL
observed	NULL
at	NULL
<	NULL
10	NULL
nM	NULL
TIMP-1	NULL
.	NULL

Saturable	NULL
cell	NULL
surface	NULL
binding	NULL
of	NULL
TIMP-1	NULL
by	NULL
JD38	NULL
cells	NULL
was	NULL
detected	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
at	NULL
levels	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
in	NULL
other	NULL
cell	NULL
lines	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Specificity	NULL
of	NULL
TIMP-1	NULL
antiapoptotic	NULL
effect	NULL
is	NULL
demonstrated	NULL
by	NULL
incubating	NULL
JD38	NULL
cells	NULL
with	NULL
TIMP-1	NULL
(	NULL
50-250	NULL
ng/m	NULL
!	NULL

1	NULL
)	NULL
,	NULL
TIMP-2	NULL
(	NULL
250-500	NULL
ng/ml	NULL
)	NULL
,	NULL
and	NULL
the	NULL
synthetic	NULL
MMP	NULL
inhibitor	NULL
BB-94	NULL
(	NULL
5	NULL
uM	NULL
)	NULL
before	NULL
cold-shock	NULL
treatment	NULL
.	NULL

Fig	NULL
.	NULL

2	NULL
B	NULL
shows	NULL
a	NULL
reduction	NULL
in	NULL
percentage	NULL
of	NULL
apoptotic	NULL
cells	NULL
as	NULL
determined	NULL
by	NULL
DNA	NULL
content	NULL
and	NULL
TUNEL	NULL
method	NULL
in	NULL
cells	NULL
pretreated	NULL
with	NULL
TIMP-1	NULL
,	NULL
while	NULL
there	NULL
is	NULL
no	NULL
decrease	NULL
in	NULL
apoptosis	NULL
in	NULL
TIMP-2	NULL
2004	NULL
-	NULL
Guedez	NULL
et	NULL
al	NULL
.	NULL

1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
TIMP-1	NULL
.	NULL

.	NULL

w	NULL
.	NULL

GAPDH	NULL
(	NULL
_	NULL
``	NULL
6	NULL
*-	NULL
0	NULL
-	NULL
0	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5°	NULL
6	NULL
7	NULL
8	NULL
9	NULL
TIMP-1	NULL
«	NULL
m	NULL
4m	NULL
(	NULL
_._	NULL
_	NULL
aa	NULL
.	NULL

'-	NULL
Figure	NULL
1	NULL
.	NULL

TIMP-1	NULL
expression	NULL
in	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
lines	NULL
.	NULL

(	NULL
top	NULL
)	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
lines	NULL
probed	NULL
with	NULL
TIMP-1	NULL
and	NULL
GAPDH	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
$	NULL
T46	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
AG876	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
EW36	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
PA682	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
Daudi	NULL
;	NULL
lane	NULL
6	NULL
,	NULL
DW6	NULL
;	NULL
lane	NULL
7	NULL
,	NULL
JD38	NULL
;	NULL
lane	NULL
8	NULL
,	NULL
Raji	NULL
;	NULL
lane	NULL
9	NULL
,	NULL
Jijyoe	NULL
.	NULL

(	NULL
bottom	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
TIMP-1	NULL
in	NULL
conditioned	NULL
media	NULL
from	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
lines	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
$	NULL
T46	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
AG876	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
EW36	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
PA682	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
Daudi	NULL
;	NULL
lane	NULL
6	NULL
,	NULL
DW6	NULL
;	NULL
lane	NULL
7	NULL
,	NULL
JD38	NULL
;	NULL
lane	NULL
8	NULL
,	NULL
Raji	NULL
;	NULL
lane	NULL
9	NULL
,	NULL
Jijyoe	NULL
.	NULL

and	NULL
BB-94-treated	NULL
cells	NULL
.	NULL

Recombinant	NULL
TIMP-1	NULL
inhibited	NULL
PCD	NULL
(	NULL
33	NULL
%	NULL
decrease	NULL
of	NULL
apoptosis	NULL
from	NULL
controls	NULL
)	NULL
by	NULL
serum	NULL
starvation	NULL
in	NULL
germinal	NULL
center	NULL
B	NULL
cells	NULL
(	NULL
CD20®	NULL
and	NULL
CD10*	NULL
)	NULL
from	NULL
tonsils	NULL
but	NULL
did	NULL
not	NULL
affect	NULL
apoptosis	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
1.2	NULL
%	NULL
decrease	NULL
of	NULL
apoptosis	NULL
from	NULL
controls	NULL
)	NULL
.	NULL

Effect	NULL
of	NULL
inactivated	NULL
TIMP-1	NULL
on	NULL
PCD	NULL
.	NULL

Chemical	NULL
reduction	NULL
and	NULL
alkylation	NULL
completely	NULL
abrogates	NULL
TIMP-1	NULL
's	NULL
ability	NULL
to	NULL
inhibit	NULL
MMP	NULL
activity	NULL
(	NULL
23	NULL
)	NULL
but	NULL
not	NULL
its	NULL
antiapoptotic	NULL
effect	NULL
.	NULL

A	NULL
decrease	NULL
in	NULL
the	NULL
percentage	NULL
of	NULL
cells	NULL
with	NULL
DNA	NULL
fragmentation	NULL
(	NULL
deter-mined	NULL
by	NULL
TUNEL/PI	NULL
staining	NULL
)	NULL
was	NULL
demonstrated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
native	NULL
as	NULL
well	NULL
as	NULL
reduced	NULL
and	NULL
alkylated	NULL
rTIMP-1	NULL
(	NULL
29+8.3	NULL
%	NULL
[	NULL
SD	NULL
]	NULL
)	NULL
and	NULL
20+6.2	NULL
%	NULL
[	NULL
SD	NULL
]	NULL
apoptotic	NULL
cells	NULL
)	NULL
,	NULL
respec-tively	NULL
,	NULL
as	NULL
compared	NULL
with	NULL
cells	NULL
cold-shocked	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
rTIMP-1	NULL
(	NULL
61+10.2	NULL
%	NULL
[	NULL
SD	NULL
]	NULL
apoptotic	NULL
cells	NULL
)	NULL
.	NULL

A	NULL
dose	NULL
of	NULL
1.4	NULL
nM	NULL
of	NULL
reduced	NULL
and	NULL
alkylated	NULL
rTIMP-1	NULL
was	NULL
as	NULL
effective	NULL
as	NULL
native	NULL
rTIMP-1	NULL
in	NULL
suppressing	NULL
cold-shock-induced	NULL
apoptosis	NULL
.	NULL

Similar	NULL
effects	NULL
are	NULL
observed	NULL
when	NULL
specific	NULL
protease	NULL
activity	NULL
associated	NULL
with	NULL
PCD	NULL
induction	NULL
is	NULL
determined	NULL
.	NULL

Caspase-3	NULL
activation	NULL
is	NULL
a	NULL
critical	NULL
event	NULL
in	NULL
the	NULL
PCD	NULL
pathway	NULL
.	NULL

Activation	NULL
of	NULL
this	NULL
protease	NULL
is	NULL
indicative	NULL
of	NULL
initiation	NULL
of	NULL
the	NULL
apoptotic	NULL
cascade	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

2	NULL
C	NULL
shows	NULL
decreased	NULL
percentage	NULL
of	NULL
cells	NULL
with	NULL
caspase-3	NULL
activity	NULL
in	NULL
JD38	NULL
cells	NULL
pretreated	NULL
with	NULL
both	NULL
native	NULL
rTIMP-1	NULL
(	NULL
13+4.0	NULL
%	NULL
[	NULL
SD	NULL
]	NULL
of	NULL
positive	NULL
cells	NULL
)	NULL
and	NULL
reduced-alkylated	NULL
rTIMP-1	NULL
(	NULL
9.0+	NULL
2.5	NULL
%	NULL
[	NULL
SD	NULL
]	NULL
of	NULL
cells	NULL
with	NULL
caspase-3	NULL
activity	NULL
)	NULL
,	NULL
compared	NULL
with	NULL
caspase-3	NULL
activity	NULL
of	NULL
cells	NULL
cold-shocked	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
exogenous	NULL
TIMP-1	NULL
(	NULL
29+5.0	NULL
%	NULL
[	NULL
SD	NULL
]	NULL
of	NULL
positive	NULL
cells	NULL
)	NULL
.	NULL

JD38	NULL
cells	NULL
have	NULL
a	NULL
demonstrable	NULL
caspase-3	NULL
activity	NULL
of	NULL
7.8+1.6	NULL
[	NULL
SD	NULL
]	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
cold	NULL
shock	NULL
.	NULL

This	NULL
further	NULL
indicates	NULL
that	NULL
TIMP-1	NULL
protective	NULL
effect	NULL
is	NULL
specific	NULL
and	NULL
is	NULL
not	NULL
due	NULL
to	NULL
inhibition	NULL
of	NULL
MMP	NULL
activity	NULL
.	NULL

Also	NULL
,	NULL
this	NULL
result	NULL
demonstrates	NULL
that	NULL
TIMP-1	NULL
modulation	NULL
of	NULL
the	NULL
apoptotic	NULL
pathway	NULL
results	NULL
in	NULL
downregulation	NULL
of	NULL
caspase-3	NULL
_	NULL
€	NULL
so	NULL
%	NULL
o	NULL
250	NULL
2	NULL
2	NULL
»	NULL
<	NULL
iso	NULL
2	NULL
100	NULL
o	NULL
O	NULL
so	NULL
©	NULL
0	NULL
g	NULL
0	NULL
0	NULL
1.43	NULL
0	NULL
14.3	NULL
0	NULL
143	NULL
Control	NULL
_	NULL
>	NULL
[	NULL
TIMP-1	NULL
]	NULL
nM	NULL
B	NULL
A	NULL
Control	NULL
TIMP-1	NULL
&	NULL
.o	NULL
fe	NULL
5	NULL
Tike	NULL
2	NULL
0	NULL
0	NULL
£	NULL
o	NULL
.	NULL

[	NULL
-=-3	NULL
G	NULL
tam	NULL
E	NULL
wre	NULL
NTK	NULL
TR	NULL
H	NULL
KT	NULL
>	NULL
DNA	NULL
Content	NULL
C	NULL
A	NULL
37°C	NULL
Control	NULL
4°	NULL
C	NULL
Control	NULL
8.9	NULL
%	NULL
32.6	NULL
%	NULL
4°	NULL
C	NULL
+TIMP-1	NULL
4°C	NULL
+R	NULL
&	NULL
A	NULL
TIMP-	NULL
16.3	NULL
%	NULL
10.8	NULL
%	NULL
l__	NULL
Relative	NULL
Cell	NULL
Number	NULL
Caspase-3	NULL
Activity	NULL
Figure	NULL
2	NULL
.	NULL

Exogenous	NULL
rTIMP-1	NULL
suppresses	NULL
PCD	NULL
and	NULL
caspase-3	NULL
in	NULL
the	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
line	NULL
JD38	NULL
.	NULL

(	NULL
A	NULL
)	NULL
TIMP-1	NULL
dose	NULL
response	NULL
in	NULL
serum-deprived	NULL
conditions	NULL
.	NULL

JD38	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
48	NULL
h	NULL
in	NULL
serum-free	NULL
media	NULL
with	NULL
1.43-143	NULL
nM	NULL
rTIMP-1	NULL
.	NULL

Results	NULL
are	NULL
reported	NULL
as	NULL
the	NULL
number	NULL
of	NULL
viable	NULL
cells	NULL
as	NULL
determined	NULL
by	NULL
Trypan	NULL
blue	NULL
exclusion	NULL
viability	NULL
assay	NULL
.	NULL

Results	NULL
represent	NULL
mean+SD	NULL
of	NULL
duplicates	NULL
of	NULL
two	NULL
analyses	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Susceptibility	NULL
to	NULL
cold-shock-induced	NULL
apoptosis	NULL
of	NULL
JD38	NULL
cells	NULL
as	NULL
determined	NULL
by	NULL
TUNEL	NULL
(	NULL
y-axis	NULL
)	NULL
and	NULL
a	NULL
shift	NULL
in	NULL
total	NULL
DNA	NULL
as	NULL
result	NULL
of	NULL
DNA	NULL
fragmentation	NULL
(	NULL
x-axis	NULL
)	NULL
.	NULL

Boxed	NULL
area	NULL
indicates	NULL
viable	NULL
cells	NULL
.	NULL

Increased	NULL
viability	NULL
(	NULL
85	NULL
%	NULL
)	NULL
is	NULL
observed	NULL
in	NULL
cells	NULL
treated	NULL
with	NULL
250	NULL
ng/ml	NULL
TIMP-1	NULL
as	NULL
compared	NULL
with	NULL
untreated	NULL
cells	NULL
(	NULL
54	NULL
%	NULL
)	NULL
while	NULL
treatment	NULL
with	NULL
500	NULL
ng/ml	NULL
TIMP-2	NULL
and	NULL
5	NULL
wM	NULL
BB-94	NULL
shows	NULL
viability	NULL
of	NULL
56	NULL
%	NULL
and	NULL
52	NULL
%	NULL
,	NULL
respectively	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Cold-shocked	NULL
cells	NULL
pretreated	NULL
with	NULL
1.4	NULL
nM	NULL
reduced	NULL
and	NULL
alkylated	NULL
(	NULL
R	NULL
&	NULL
A	NULL
)	NULL
TIMP-1	NULL
also	NULL
show	NULL
a	NULL
decreased	NULL
number	NULL
of	NULL
cells	NULL
with	NULL
caspase-3	NULL
activity	NULL
(	NULL
10.8	NULL
%	NULL
)	NULL
similar	NULL
to	NULL
the	NULL
effect	NULL
of	NULL
native	NULL
protein	NULL
(	NULL
TIMP-1	NULL
)	NULL
while	NULL
an	NULL
increased	NULL
caspase	NULL
activity	NULL
(	NULL
32	NULL
%	NULL
)	NULL
is	NULL
observed	NULL
in	NULL
cells	NULL
cold-shocked	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
TIMP-1	NULL
(	NULL
untreated	NULL
)	NULL
.	NULL

Endogenous	NULL
caspase-3	NULL
activity	NULL
at	NULL
37°C	NULL
is	NULL
also	NULL
shown	NULL
.	NULL

Similar	NULL
results	NULL
obtained	NULL
with	NULL
TUNEL/PI	NULL
are	NULL
discussed	NULL
in	NULL
the	NULL
text	NULL
.	NULL

x-axis	NULL
,	NULL
log	NULL
fluorescence	NULL
re	NULL
activity	NULL
and	NULL
suggests	NULL
that	NULL
TIMP-1	NULL
effects	NULL
are	NULL
mediated	NULL
upstream	NULL
of	NULL
activation	NULL
of	NULL
this	NULL
cell-death	NULL
protease	NULL
.	NULL

TIMP-1	NULL
does	NULL
not	NULL
inhibit	NULL
caspase-3	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

TIMP-1	NULL
upregulation	NULL
in	NULL
JD38	NULL
cells	NULL
inhibits	NULL
PCD	NULL
.	NULL

A	NULL
direct	NULL
TIMP-1	NULL
effect	NULL
was	NULL
demonstrated	NULL
by	NULL
inducing	NULL
TIMP-1	NULL
expression	NULL
in	NULL
the	NULL
EBV-negative	NULL
JD38	NULL
cells	NULL
and	NULL
selection	NULL
of	NULL
independent	NULL
cell	NULL
clones	NULL
as	NULL
explained	NULL
in	NULL
Methods	NULL
.	NULL

Fig	NULL
.	NULL

3	NULL
A	NULL
shows	NULL
expression	NULL
of	NULL
TIMP-1	NULL
in	NULL
parent	NULL
cells	NULL
,	NULL
three	NULL
clones	NULL
carrying	NULL
empty	NULL
LXSN	NULL
vector	NULL
,	NULL
and	NULL
four	NULL
TIMP-1-JD38	NULL
cell	NULL
clones	NULL
as	NULL
detected	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
conditioned	NULL
media	NULL
demonstrated	NULL
TIMP-1	NULL
expression	NULL
and	NULL
secretion	NULL
by	NULL
the	NULL
TIMP-1-expressing	NULL
clones	NULL
T8	NULL
,	NULL
T20	NULL
,	NULL
and	NULL
T24	NULL
but	NULL
not	NULL
detectable	NULL
TIMP-1	NULL
in	NULL
the	NULL
parental	NULL
line	NULL
JD38	NULL
or	NULL
LXSN	NULL
controls	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
B	NULL
)	NULL
.	NULL

The	NULL
TIMP-1	NULL
protein	NULL
was	NULL
functional	NULL
as	NULL
demonstrated	NULL
by	NULL
reverse	NULL
zymography	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
JD38	NULL
parental	NULL
cells	NULL
,	NULL
LXSN-JD38	NULL
cell	NULL
clones	NULL
,	NULL
as	NULL
well	NULL
as	NULL
TIMP-1-JD38	NULL
cell	NULL
clones	NULL
,	NULL
were	NULL
examined	NULL
for	NULL
susceptibility	NULL
to	NULL
induction	NULL
of	NULL
PCD	NULL
by	NULL
various	NULL
stimuli	NULL
.	NULL

Cells	NULL
were	NULL
observed	NULL
periodically	NULL
from	NULL
4-72	NULL
h	NULL
after	NULL
any	NULL
of	NULL
the	NULL
following	NULL
treatments	NULL
:	NULL
cold	NULL
shock	NULL
at	NULL
4°C	NULL
,	NULL
anti-CD95	NULL
(	NULL
anti-Fas/APO	NULL
)	NULL
activating	NULL
antibody	NULL
,	NULL
serum	NULL
deprivation	NULL
,	NULL
or	NULL
y-radiation	NULL
.	NULL

PCD	NULL
was	NULL
assessed	NULL
by	NULL
morphology	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
TUNEL	NULL
method	NULL
(	NULL
TdT	NULL
incorporation	NULL
of	NULL
labeled	NULL
nucleotides	NULL
into	NULL
DNA	NULL
strand	NULL
breaks	NULL
)	NULL
,	NULL
PI	NULL
staining	NULL
(	NULL
decreased	NULL
DNA	NULL
content	NULL
due	NULL
to	NULL
DNA	NULL
fragmentation	NULL
)	NULL
,	NULL
and	NULL
light	NULL
scatter	NULL
changes	NULL
(	NULL
decreasing	NULL
size	NULL
and	NULL
increasing	NULL
granularity	NULL
of	NULL
cells	NULL
,	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Table	NULL
II	NULL
shows	NULL
a	NULL
summary	NULL
of	NULL
percentage	NULL
of	NULL
apoptotic	NULL
cells	NULL
as	NULL
determined	NULL
by	NULL
TUNEL/PI	NULL
after	NULL
treatment	NULL
for	NULL
each	NULL
of	NULL
the	NULL
JD38	NULL
cell	NULL
lines	NULL
.	NULL

Induction	NULL
of	NULL
TIMP-1	NULL
expression	NULL
in	NULL
three	NULL
independent	NULL
JD38	NULL
cell	NULL
clones	NULL
,	NULL
each	NULL
with	NULL
a	NULL
unique	NULL
integration	NULL
site	NULL
,	NULL
is	NULL
associated	NULL
with	NULL
inhibition	NULL
of	NULL
apoptosis	NULL
initiated	NULL
by	NULL
all	NULL
methods	NULL
studied	NULL
as	NULL
shown	NULL
in	NULL
Table	NULL
II	NULL
.	NULL

Moreover	NULL
,	NULL
neutralization	NULL
of	NULL
secreted	NULL
TIMP-1	NULL
in	NULL
clones	NULL
T20	NULL
and	NULL
T24	NULL
with	NULL
monoclonal	NULL
anti-TIMP-1	NULL
antibody	NULL
restored	NULL
sensitivity	NULL
to	NULL
serum	NULL
starvation	NULL
while	NULL
treatment	NULL
with	NULL
anti-TIMP-2	NULL
or	NULL
isotype	NULL
control	NULL
did	NULL
not	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
it	NULL
is	NULL
secreted	NULL
TIMP-1	NULL
that	NULL
prevents	NULL
apoptosis	NULL
.	NULL

These	NULL
results	NULL
in	NULL
conjunction	NULL
with	NULL
our	NULL
preliminary	NULL
observations	NULL
of	NULL
cell	NULL
surface	NULL
binding	NULL
of	NULL
TIMP-1	NULL
by	NULL
JD38	NULL
cells	NULL
suggest	NULL
that	NULL
TIMP-1	NULL
effect	NULL
may	NULL
be	NULL
receptor	NULL
medi-ated	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
TIMP-1	NULL
protective	NULL
effect	NULL
was	NULL
dependent	NULL
on	NULL
withdrawal	NULL
from	NULL
cell	NULL
cycle	NULL
,	NULL
parent	NULL
,	NULL
LXSN-JD38	NULL
,	NULL
and	NULL
TIMP-1-D38	NULL
cell	NULL
clones	NULL
20	NULL
and	NULL
24	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
serum	NULL
for	NULL
1-5	NULL
d	NULL
,	NULL
and	NULL
changes	NULL
in	NULL
cell	NULL
cycle	NULL
distribution	NULL
were	NULL
detected	NULL
by	NULL
PI	NULL
staining	NULL
and	NULL
DNA	NULL
synthesis	NULL
monitored	NULL
by	NULL
BRDU	NULL
uptake	NULL
.	NULL

Fig	NULL
.	NULL

5	NULL
shows	NULL
flow	NULL
cytometric	NULL
analysis	NULL
of	NULL
these	NULL
parameters	NULL
for	NULL
LXSN-JD38	NULL
and	NULL
TIMP-1-JD38	NULL
clone	NULL
24	NULL
.	NULL

A	NULL
decreasing	NULL
percentage	NULL
of	NULL
cells	NULL
incorporating	NULL
BRDU	NULL
is	NULL
demonstrated	NULL
by	NULL
control	NULL
LXSN-JD38	NULL
cells	NULL
,	NULL
with	NULL
44.3	NULL
%	NULL
of	NULL
cells	NULL
synthesizing	NULL
DNA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
serum	NULL
,	NULL
decreasing	NULL
to	NULL
9.6	NULL
%	NULL
by	NULL
48	NULL
h	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
serum	NULL
.	NULL

TIMP-1-JD38	NULL
cells	NULL
demonstrate	NULL
a	NULL
higher	NULL
percentage	NULL
of	NULL
cells	NULL
actively	NULL
incorporating	NULL
nucleotides	NULL
throughout	NULL
the	NULL
same	NULL
treatment	NULL
times	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
both	NULL
that	NULL
the	NULL
TIMP-1-protective	NULL
effect	NULL
does	NULL
not	NULL
involve	NULL
cell	NULL
cycle	NULL
perturbations	NULL
and	NULL
that	NULL
control	NULL
cells	NULL
die	NULL
while	NULL
progressing	NULL
through	NULL
the	NULL
cycle	NULL
.	NULL

Effects	NULL
of	NULL
TIMP-1	NULL
on	NULL
apoptotic	NULL
proteins	NULL
.	NULL

Bcel-2	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
inhibit	NULL
apoptosis	NULL
in	NULL
B	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
in	NULL
numerous	NULL
other	NULL
cell	NULL
sulting	NULL
from	NULL
the	NULL
cleavage	NULL
of	NULL
flourogenic	NULL
peptide	NULL
specific	NULL
for	NULL
caspase-3	NULL
;	NULL
y-axis	NULL
,	NULL
percentage	NULL
of	NULL
cells	NULL
.	NULL

Representative	NULL
data	NULL
of	NULL
triplicate	NULL
determinations	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

TIMP-1	NULL
Suppression	NULL
of	NULL
Programmed	NULL
Cell	NULL
Death	NULL
in	NULL
B	NULL
Cells	NULL
_	NULL
2005	NULL
Table	NULL
II	NULL
.	NULL

Summary	NULL
of	NULL
Induction	NULL
of	NULL
Programmed	NULL
Cell	NULL
Death	NULL
in	NULL
JD38	NULL
Cells	NULL
with	NULL
Retroviral	NULL
Transduced	NULL
TIMP-1	NULL
Expression	NULL
as	NULL
Determined	NULL
by	NULL
TUNEL/PI	NULL
Method	NULL
for	NULL
induction	NULL
of	NULL
programmed	NULL
cell	NULL
death	NULL
(	NULL
%	NULL
apoptotic	NULL
cells	NULL
)	NULL
Cell	NULL
line	NULL
Untreated	NULL
Cold	NULL
shock	NULL
anti-FAS	NULL
y-Radiation	NULL
Serum	NULL
free	NULL
JD38	NULL
8.4+4.3	NULL
56.3+7.5	NULL
29.0+8.0	NULL
32.0+1.4	NULL
87.0+3.0	NULL
LXSN	NULL
(	NULL
Control	NULL
)	NULL
5.8+2.7	NULL
43.6+9.0	NULL
40.0+13.0	NULL
34.1+5.7	NULL
78.0+13.0	NULL
TIMP-1	NULL
(	NULL
Clone	NULL
8	NULL
)	NULL
2430.6	NULL
1.3+0.9	NULL
TIMP-1	NULL
(	NULL
Clone	NULL
20	NULL
)	NULL
5.5+3.5	NULL
8.1+0.6	NULL
5.4+3.4	NULL
3.2+1.2	NULL
6.1+2.5	NULL
TIMP-1	NULL
(	NULL
Clone	NULL
24	NULL
)	NULL
34+1.1	NULL
13.2+9.0	NULL
2.1+0.1	NULL
4.7+1.2	NULL
5.7+0.8	NULL
Apoptosis	NULL
was	NULL
detected	NULL
by	NULL
TUNEL	NULL
in	NULL
conjunction	NULL
with	NULL
PI	NULL
staining	NULL
for	NULL
the	NULL
detection	NULL
of	NULL
sub	NULL
Go/G1	NULL
DNA	NULL
peak	NULL
as	NULL
explained	NULL
in	NULL
Methods	NULL
.	NULL

These	NULL
results	NULL
were	NULL
confirmed	NULL
by	NULL
at	NULL
least	NULL
three	NULL
methods	NULL
:	NULL
light-microscopy	NULL
morphology	NULL
,	NULL
forward	NULL
and	NULL
side	NULL
scatter	NULL
,	NULL
and	NULL
caspase-3	NULL
activity	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
percentage	NULL
of	NULL
apoptotic	NULL
cells	NULL
,	NULL
mean+SD	NULL
of	NULL
duplicate	NULL
determinations	NULL
of	NULL
three	NULL
flow-cytometric	NULL
analyses	NULL
.	NULL

types	NULL
(	NULL
1	NULL
,	NULL
2	NULL
,	NULL
24-26	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
Bel-2	NULL
or	NULL
related	NULL
proteins	NULL
are	NULL
implicated	NULL
in	NULL
the	NULL
TIMP-1	NULL
protective	NULL
effect	NULL
,	NULL
TIMP-1-JD38	NULL
cell	NULL
clones	NULL
and	NULL
control	NULL
LXSN	NULL
and	NULL
parent	NULL
JD38	NULL
cells	NULL
were	NULL
assayed	NULL
for	NULL
their	NULL
expression	NULL
of	NULL
these	NULL
antiapoptotic	NULL
proteins	NULL
by	NULL
Western	NULL
analysis	NULL
.	NULL

Although	NULL
both	NULL
control	NULL
and	NULL
TIMP-1-JD38	NULL
express	NULL
Bcl-2	NULL
,	NULL
upregulation	NULL
of	NULL
TIMP-1	NULL
does	NULL
not	NULL
further	NULL
enhance	NULL
expression	NULL
of	NULL
this	NULL
protein	NULL
.	NULL

However	NULL
,	NULL
induction	NULL
of	NULL
TIMP-1	NULL
clearly	NULL
upregulates	NULL
Bcl-X	NULL
;	NULL
,	NULL
in	NULL
TIMP-1-JD38	NULL
cell	NULL
clones	NULL
as	NULL
compared	NULL
with	NULL
LXSN-JD38	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
cells	NULL
were	NULL
all	NULL
negative	NULL
for	NULL
the	NULL
Bel-2	NULL
homologue	NULL
Mcl-1	NULL
(	NULL
27	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
controlling	NULL
several	NULL
genes	NULL
in	NULL
B	NULL
lymphocytes	NULL
,	NULL
including	NULL
immunoglobulin	NULL
light	NULL
chain	NULL
gene	NULL
,	NULL
the	NULL
transcription	NULL
factor	NULL
NF-kB	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
regulate	NULL
expression	NULL
of	NULL
genes	NULL
involved	NULL
in	NULL
apoptosis	NULL
(	NULL
28-30	NULL
)	NULL
.	NULL

After	NULL
immunodetection	NULL
of	NULL
Bel-X	NULL
;	NULL
,	NULL
A	NULL
LXSN	NULL
--	NULL
TIMPA1	NULL
D	NULL
C4	NULL
C7	NULL
C9	NULL
8	NULL
18	NULL
20	NULL
2	NULL
TIMP-1	NULL
GAPDH	NULL
B	NULL
LXSN	NULL
TIMP-1	NULL
D	NULL
C4	NULL
C7	NULL
8	NULL
20	NULL
24	NULL
+	NULL
.	NULL

-	NULL
30	NULL
kDa	NULL
Figure	NULL
3	NULL
.	NULL

TIMP-1	NULL
expression	NULL
in	NULL
LXSN-transduced	NULL
JD38	NULL
cells	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
parent	NULL
line	NULL
JD38	NULL
(	NULL
lane	NULL
D	NULL
)	NULL
,	NULL
LXSN	NULL
vector	NULL
control	NULL
clones	NULL
(	NULL
lanes	NULL
C4	NULL
,	NULL
C7	NULL
,	NULL
and	NULL
C9	NULL
)	NULL
,	NULL
and	NULL
LXSN-TIMP-1	NULL
clones	NULL
(	NULL
lanes	NULL
8	NULL
,	NULL
18	NULL
,	NULL
20	NULL
,	NULL
and	NULL
24	NULL
)	NULL
.	NULL

Northern	NULL
blots	NULL
were	NULL
probed	NULL
for	NULL
TIMP-1	NULL
and	NULL
reprobed	NULL
with	NULL
GAPDH	NULL
probe	NULL
for	NULL
loading	NULL
control	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
secreted	NULL
TIMP-1	NULL
in	NULL
parent	NULL
JD38	NULL
cells	NULL
(	NULL
lane	NULL
D	NULL
)	NULL
,	NULL
LXSN	NULL
vector	NULL
control	NULL
clones	NULL
(	NULL
lanes	NULL
C4	NULL
and	NULL
C7	NULL
)	NULL
,	NULL
and	NULL
LXSN-TIMP-1	NULL
clones	NULL
(	NULL
lanes	NULL
8	NULL
,	NULL
20	NULL
,	NULL
and	NULL
24	NULL
)	NULL
;	NULL
rTIMP-1	NULL
(	NULL
50	NULL
ng	NULL
)	NULL
was	NULL
used	NULL
as	NULL
positive	NULL
control	NULL
(	NULL
lane	NULL
+	NULL
)	NULL
.	NULL

Lane	NULL
numbers	NULL
correspond	NULL
to	NULL
clone	NULL
numbers	NULL
.	NULL

2006	NULL
-	NULL
Guedez	NULL
et	NULL
al	NULL
.	NULL

the	NULL
same	NULL
blot	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
was	NULL
reprobed	NULL
with	NULL
an	NULL
antibody	NULL
against	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
(	NULL
Rel	NULL
A	NULL
)	NULL
.	NULL

No	NULL
change	NULL
in	NULL
the	NULL
cytoplasmic	NULL
expression	NULL
of	NULL
NF-kB	NULL
was	NULL
observed	NULL
for	NULL
any	NULL
of	NULL
JD38	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

However	NULL
,	NULL
higher	NULL
expression	NULL
of	NULL
the	NULL
NF-kB	NULL
inhibitor	NULL
IxBa	NULL
is	NULL
observed	NULL
in	NULL
TIMP-1-expressing	NULL
cell	NULL
clones	NULL
(	NULL
20	NULL
,	NULL
24	NULL
)	NULL
,	NULL
indicating	NULL
a	NULL
decreased	NULL
in	NULL
NF-kB	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
TIMP-1	NULL
suppression	NULL
of	NULL
PCD	NULL
did	NULL
not	NULL
correlate	NULL
with	NULL
levels	NULL
of	NULL
cell	NULL
surface	NULL
CD95	NULL
expression	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
TIMP-1	NULL
antiapoptotic	NULL
mechanism	NULL
is	NULL
not	NULL
mediated	NULL
by	NULL
Bel-2	NULL
or	NULL
suppression	NULL
of	NULL
CD95	NULL
expression	NULL
,	NULL
but	NULL
likely	NULL
by	NULL
inducing	NULL
Bcl-X	NULL
;	NULL
.	NULL

J	NULL
»	NULL
ilsotype	NULL
CTL	NULL
Figure	NULL
4	NULL
.	NULL

Neutralization	NULL
of	NULL
TIMP-1	NULL
reverses	NULL
PCD	NULL
suppression	NULL
.	NULL

TIMP-1-JD38	NULL
cell	NULL
clones	NULL
were	NULL
incubated	NULL
for	NULL
48	NULL
h	NULL
in	NULL
serum-free	NULL
media	NULL
with	NULL
5	NULL
g/ml	NULL
of	NULL
the	NULL
following	NULL
murine	NULL
monoclonal	NULL
an-tibodies	NULL
:	NULL
isotype	NULL
control	NULL
(	NULL
A	NULL
)	NULL
,	NULL
anti-TIMP-2	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
anti-TIMP-1	NULL
(	NULL
C	NULL
)	NULL
.	NULL

Boxed	NULL
region	NULL
indicates	NULL
viable	NULL
cells	NULL
.	NULL

Treatment	NULL
with	NULL
anti-TIMP-1	NULL
decreased	NULL
percentage	NULL
of	NULL
viable	NULL
cells	NULL
(	NULL
66.2	NULL
%	NULL
)	NULL
due	NULL
to	NULL
apoptosis	NULL
as	NULL
compared	NULL
with	NULL
isotype	NULL
control	NULL
(	NULL
85.0	NULL
%	NULL
)	NULL
and	NULL
anti-TIMP-2	NULL
(	NULL
87.05	NULL
%	NULL
)	NULL
.	NULL

Apoptosis	NULL
was	NULL
determined	NULL
by	NULL
TUNEL	NULL
(	NULL
y-axis	NULL
)	NULL
and	NULL
shift	NULL
in	NULL
DNA	NULL
content	NULL
by	NULL
propidium	NULL
iodide	NULL
(	NULL
x-axis	NULL
)	NULL
as	NULL
explained	NULL
in	NULL
Methods	NULL
.	NULL

-	NULL
FBS	NULL
24	NULL
H	NULL
-	NULL
FBS	NULL
48	NULL
H	NULL
LXSN-JD38	NULL
ae	NULL
~	NULL
~4	NULL
e4	NULL
(	NULL
P.	NULL
P4	NULL
2	NULL
16.4	NULL
%	NULL
o	NULL
9.6	NULL
%	NULL
ce	NULL
``	NULL
Pbo	NULL
-	NULL
4b0	NULL
-	NULL
600	NULL
_	NULL
800	NULL
250	NULL
~	NULL
abo	NULL
abo	NULL
abe	NULL
~	NULL
200	NULL
400	NULL
-	NULL
600	NULL
_	NULL
ann	NULL
mol	NULL
I	NULL
8	NULL
.	NULL

*I	NULL
°3	NULL
~	NULL
TIMP-1-JD38	NULL
-	NULL
,	NULL
~	NULL
.	NULL

E	NULL
~I	NULL
E	NULL
1	NULL
1	NULL
48.2	NULL
%	NULL
I	NULL
=	NULL
``	NULL
bo	NULL
-	NULL
4006	NULL
-	NULL
600	NULL
_	NULL
800	NULL
250	NULL
~	NULL
250	NULL
~	NULL
000	NULL
*	NULL
abo	NULL
~	NULL
200	NULL
400	NULL
600	NULL
800	NULL
DNA	NULL
CONTENT	NULL
--	NULL
--	NULL
Figure	NULL
5	NULL
.	NULL

Effect	NULL
on	NULL
DNA	NULL
synthesis	NULL
of	NULL
upregulated	NULL
TIMP-1	NULL
in	NULL
JD38	NULL
cells	NULL
.	NULL

Parent	NULL
JD38	NULL
cells	NULL
,	NULL
LXSN-JD38	NULL
,	NULL
and	NULL
TIMP-JD38	NULL
cell	NULL
clones	NULL
were	NULL
incu-	NULL
bated	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
+	NULL
FBS	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
-	NULL
FBS	NULL
)	NULL
of	NULL
serum	NULL
for	NULL
1-5	NULL
d	NULL
;	NULL
DNA	NULL
synthesis	NULL
was	NULL
monitored	NULL
by	NULL
BRDU	NULL
(	NULL
y-axis	NULL
)	NULL
uptake	NULL
as	NULL
explained	NULL
in	NULL
Methods	NULL
,	NULL
and	NULL
cell	NULL
cycle	NULL
distribution	NULL
by	NULL
staining	NULL
total	NULL
DNA	NULL
with	NULL
propidium	NULL
iodine	NULL
(	NULL
x-axis	NULL
)	NULL
,	NULL
flow	NULL
cytometric	NULL
analysis	NULL
of	NULL
dot	NULL
plots	NULL
is	NULL
shown	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
serum	NULL
condition	NULL
,	NULL
serum-deprived	NULL
LXSN-JD38	NULL
cells	NULL
show	NULL
a	NULL
continuing	NULL
reduction	NULL
in	NULL
the	NULL
fraction	NULL
of	NULL
cells	NULL
actively	NULL
synthesizing	NULL
DNA	NULL
(	NULL
boxed	NULL
)	NULL
,	NULL
while	NULL
TIMP-1-JD38	NULL
clone	NULL
24	NULL
cells	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
maintain	NULL
similar	NULL
percentage	NULL
of	NULL
BRDU	NULL
uptake	NULL
as	NULL
those	NULL
of	NULL
TIMP-JD38	NULL
cells	NULL
in	NULL
serum	NULL
.	NULL

Only	NULL
results	NULL
from	NULL
24	NULL
and	NULL
48	NULL
h	NULL
are	NULL
shown	NULL
.	NULL

By	NULL
day	NULL
5	NULL
,	NULL
BRDU	NULL
uptake	NULL
in	NULL
parent	NULL
JD38	NULL
,	NULL
LXSN	NULL
,	NULL
and	NULL
TIMP-1	NULL
JD38	NULL
was	NULL
3.84	NULL
%	NULL
,	NULL
4.97	NULL
%	NULL
,	NULL
and	NULL
18.75	NULL
%	NULL
,	NULL
respectively	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
upregulation	NULL
of	NULL
Bel-X	NULL
;	NULL
,	NULL
by	NULL
TIMP-1	NULL
appears	NULL
to	NULL
be	NULL
independent	NULL
from	NULL
NF-kB	NULL
activation	NULL
in	NULL
TIMP-1-expressing	NULL
JD38	NULL
cells	NULL
.	NULL

Discussion	NULL
The	NULL
extracellular	NULL
matrix	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
apoptosis	NULL
of	NULL
epithelial	NULL
cells	NULL
in	NULL
an	NULL
attachment-dependent	NULL
fashion	NULL
.	NULL

In	NULL
these	NULL
studies	NULL
,	NULL
ECM	NULL
was	NULL
demonstrated	NULL
to	NULL
modulate	NULL
PCD	NULL
and	NULL
effectors	NULL
such	NULL
as	NULL
capases	NULL
through	NULL
integrin	NULL
receptors	NULL
(	NULL
4	NULL
)	NULL
.	NULL

More	NULL
recently	NULL
,	NULL
extracellular	NULL
matrix	NULL
factors	NULL
were	NULL
shown	NULL
to	NULL
control	NULL
PCD	NULL
of	NULL
hemato-lymphoid	NULL
cells	NULL
(	NULL
5	NULL
,	NULL
6	NULL
,	NULL
31	NULL
)	NULL
.	NULL

Using	NULL
a	NULL
human	NULL
melanoma	NULL
cell	NULL
line	NULL
,	NULL
Valente	NULL
et	NULL
al	NULL
.	NULL

have	NULL
shown	NULL
that	NULL
TIMP-2	NULL
inhibits	NULL
tumor	NULL
cell	NULL
invasion	NULL
and	NULL
that	NULL
TIMP-2	NULL
overexpressing	NULL
tumor	NULL
clones	NULL
were	NULL
found	NULL
to	NULL
be	NULL
more	NULL
resistant	NULL
to	NULL
apoptosis	NULL
than	NULL
parental	NULL
and	NULL
control	NULL
melanoma	NULL
cells	NULL
(	NULL
32	NULL
)	NULL
.	NULL

A	NULL
recent	NULL
report	NULL
in	NULL
this	NULL
journal	NULL
demonstrates	NULL
that	NULL
TIMP-3	NULL
promotes	NULL
apoptosis	NULL
in	NULL
rat	NULL
vascular	NULL
smooth	NULL
muscle	NULL
cells	NULL
(	NULL
33	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
support	NULL
the	NULL
idea	NULL
that	NULL
TIMPs	NULL
can	NULL
exert	NULL
different	NULL
activities	NULL
in	NULL
addition	NULL
to	NULL
inhibition	NULL
of	NULL
MMP	NULL
,	NULL
including	NULL
modulation	NULL
of	NULL
PCD	NULL
.	NULL

However	NULL
,	NULL
in	NULL
both	NULL
of	NULL
these	NULL
studies	NULL
,	NULL
the	NULL
mechanism	NULL
for	NULL
the	NULL
effect	NULL
of	NULL
TIMP-2	NULL
and	NULL
TIMP-3	NULL
on	NULL
PCD	NULL
is	NULL
not	NULL
addressed	NULL
.	NULL

Our	NULL
laboratory	NULL
and	NULL
others	NULL
have	NULL
previously	NULL
reported	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
MMPs	NULL
and	NULL
their	NULL
endogenous	NULL
inhibitors	NULL
(	NULL
TIMPs	NULL
)	NULL
by	NULL
normal	NULL
and	NULL
neoplastic	NULL
lymphocytes	NULL
(	NULL
7	NULL
,	NULL
34	NULL
)	NULL
.	NULL

We	NULL
have	NULL
found	NULL
high-level	NULL
expression	NULL
of	NULL
TIMP-1	NULL
in	NULL
normal	NULL
activated	NULL
tonsillar	NULL
B	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
in	NULL
high-grade	NULL
B	NULL
cell	NULL
lymphoma	NULL
cell	NULL
lines	NULL
,	NULL
frequently	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
MMP	NULL
expression	NULL
(	NULL
7	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
have	NULL
found	NULL
TIMP-1	NULL
expression	NULL
is	NULL
associated	NULL
with	NULL
resistance	NULL
to	NULL
apoptosis	NULL
in	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
lines	NULL
and	NULL
that	NULL
TIMP-1	NULL
can	NULL
inhibit	NULL
apoptosis	NULL
in	NULL
normal	NULL
tonsillar	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
suppression	NULL
of	NULL
PCD	NULL
is	NULL
a	NULL
novel	NULL
action	NULL
for	NULL
TIMP-1	NULL
.	NULL

Our	NULL
data	NULL
further	NULL
demonstrates	NULL
that	NULL
this	NULL
effect	NULL
is	NULL
TIMP-1	NULL
specific	NULL
and	NULL
is	NULL
not	NULL
secondary	NULL
to	NULL
MMP	NULL
inhibition	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
TIMP-1	NULL
to	NULL
inhibit	NULL
apoptosis	NULL
in	NULL
an	NULL
MMP	NULL
-independent	NULL
manner	NULL
is	NULL
consistent	NULL
with	NULL
observations	NULL
of	NULL
growth	NULL
promotion	NULL
by	NULL
TIMPs	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
types	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Hayakawa	NULL
et	NULL
al	NULL
.	NULL

have	NULL
shown	NULL
that	NULL
TIMP-1	NULL
promotes	NULL
cell	NULL
survival	NULL
in	NULL
serum-free	NULL
conditions	NULL
for	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
cell	NULL
lines	NULL
sensitive	NULL
to	NULL
serum	NULL
deprivation	NULL
including	NULL
lymphoid	NULL
,	NULL
myeloid	NULL
,	NULL
endothelial	NULL
,	NULL
fibroblasts	NULL
,	NULL
hepatoma	NULL
,	NULL
breast	NULL
carcinoma	NULL
,	NULL
and	NULL
chondrocyte	NULL
cell	NULL
lines	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Although	NULL
these	NULL
authors	NULL
did	NULL
not	NULL
measure	NULL
apoptosis	NULL
in	NULL
these	NULL
cell	NULL
lines	NULL
,	NULL
it	NULL
is	NULL
known	NULL
that	NULL
they	NULL
do	NULL
undergo	NULL
apoptosis	NULL
under	NULL
conditions	NULL
of	NULL
serum	NULL
starvation	NULL
.	NULL

Addition	NULL
of	NULL
TIMP-1	NULL
was	NULL
sufficient	NULL
to	NULL
maintain	NULL
cell	NULL
growth	NULL
and	NULL
viability	NULL
,	NULL
suggesting	NULL
that	NULL
TIMP-1	NULL
may	NULL
have	NULL
inhibited	NULL
serum-starvation	NULL
induced	NULL
PCD	NULL
in	NULL
these	NULL
lines	NULL
representing	NULL
multiple	NULL
lineages	NULL
.	NULL

TIMP-1	NULL
inhibits	NULL
apoptosis	NULL
in	NULL
mouse	NULL
mammary	NULL
epithelial	NULL
cells	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

This	NULL
effect	NULL
was	NULL
attributed	NULL
to	NULL
inhibition	NULL
of	NULL
MMP	NULL
activity	NULL
and	NULL
preservation	NULL
of	NULL
cell-matrix	NULL
contacts	NULL
.	NULL

The	NULL
possible	NULL
direct	NULL
antiapoptotic	NULL
effect	NULL
of	NULL
TIMP-1	NULL
was	NULL
not	NULL
examined	NULL
in	NULL
this	NULL
system	NULL
.	NULL

Preservation	NULL
of	NULL
cell-matrix	NULL
is	NULL
clearly	NULL
not	NULL
the	NULL
mechanism	NULL
of	NULL
TIMP-1	NULL
suppression	NULL
of	NULL
PCD	NULL
in	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
lines	NULL
.	NULL

First	NULL
,	NULL
reduced-alkylated	NULL
TIMP-1	NULL
,	NULL
completely	NULL
devoid	NULL
of	NULL
MMP	NULL
inhibitory	NULL
activity	NULL
,	NULL
results	NULL
in	NULL
PCD	NULL
suppression	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
TIMP-2	NULL
or	NULL
the	NULL
synthetic	NULL
inhibitor	NULL
BB-94	NULL
failed	NULL
to	NULL
protect	NULL
from	NULL
PCD	NULL
,	NULL
even	NULL
though	NULL
the	NULL
levels	NULL
of	NULL
BB-94	NULL
used	NULL
should	NULL
completely	NULL
inhibit	NULL
a	NULL
wide	NULL
spectrum	NULL
of	NULL
metalloproteinases	NULL
,	NULL
including	NULL
MMPs	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
TIMP-1	NULL
to	NULL
exert	NULL
antiapoptotic	NULL
effects	NULL
independently	NULL
of	NULL
its	NULL
MMP	NULL
inhibitory	NULL
effect	NULL
is	NULL
consistent	NULL
with	NULL
other	NULL
studies	NULL
that	NULL
demonstrated	NULL
TIMP-1	NULL
cell	NULL
growth	NULL
modulatory	NULL
effects	NULL
unrelated	NULL
to	NULL
its	NULL
ability	NULL
to	NULL
act	NULL
as	NULL
MMP	NULL
inhibitor	NULL
(	NULL
12	NULL
)	NULL
.	NULL

TIMP-1	NULL
Suppression	NULL
of	NULL
Programmed	NULL
Cell	NULL
Death	NULL
in	NULL
B	NULL
Cells	NULL
_	NULL
2007	NULL
Bcl-2	NULL
Cg	NULL
mwy	NULL
=	NULL
,	NULL
as	NULL
x	NULL
Bcl-X	NULL
,	NULL
C	NULL
@	NULL
‘	NULL
~	NULL
UV	NULL
NF-xB	NULL
IxBo	NULL
menores	NULL
Figure	NULL
6	NULL
.	NULL

Expression	NULL
of	NULL
Bel-2-related	NULL
proteins	NULL
in	NULL
JD38	NULL
cell	NULL
lines	NULL
.	NULL

Expression	NULL
of	NULL
Bel-2	NULL
,	NULL
Bel-X	NULL
;	NULL
,	NULL
s	NULL
in	NULL
parent	NULL
JD38	NULL
cells	NULL
,	NULL
LXSN-JD38	NULL
,	NULL
and	NULL
TIMP-1-JD38	NULL
clones	NULL
20	NULL
,	NULL
24	NULL
were	NULL
detected	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
as	NULL
explained	NULL
in	NULL
Methods	NULL
.	NULL

Parental	NULL
and	NULL
LXSN-JD38	NULL
cells	NULL
express	NULL
equal	NULL
levels	NULL
of	NULL
Bel-2	NULL
,	NULL
demonstrating	NULL
that	NULL
upregulation	NULL
of	NULL
TIMP-1	NULL
in	NULL
JD38	NULL
cells	NULL
does	NULL
not	NULL
significantly	NULL
enhance	NULL
Bel-2	NULL
expression	NULL
.	NULL

Upregulation	NULL
of	NULL
TIMP-1	NULL
in	NULL
JD38	NULL
cells	NULL
induces	NULL
higher	NULL
expression	NULL
of	NULL
Bel-X	NULL
;	NULL
,	NULL
in	NULL
TIMP-1-JD38	NULL
cell	NULL
clones	NULL
20	NULL
and	NULL
24	NULL
as	NULL
compared	NULL
with	NULL
LXSN-JD38	NULL
controls	NULL
.	NULL

A	NULL
high	NULL
TIMP-1	NULL
expressing	NULL
Burkitt	NULL
's	NULL
line	NULL
AG876	NULL
is	NULL
included	NULL
as	NULL
positive	NULL
control	NULL
(	NULL
+	NULL
CTL	NULL
)	NULL
.	NULL

The	NULL
same	NULL
Bel-X	NULL
blot	NULL
was	NULL
stripped	NULL
and	NULL
reprobed	NULL
with	NULL
antibody	NULL
against	NULL
p-65	NULL
NF-kB	NULL
.	NULL

No	NULL
significant	NULL
changes	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
is	NULL
observed	NULL
in	NULL
JD38	NULL
cell	NULL
lines	NULL
,	NULL
indicating	NULL
that	NULL
upregulation	NULL
of	NULL
TIMP-1	NULL
does	NULL
not	NULL
affect	NULL
cytoplasmic	NULL
concentration	NULL
of	NULL
NF-kB	NULL
.	NULL

However	NULL
,	NULL
TIMP-1	NULL
upregulation	NULL
induces	NULL
the	NULL
inhibitor	NULL
IxBa	NULL
suggesting	NULL
a	NULL
decrease	NULL
in	NULL
NF-kB	NULL
activation	NULL
.	NULL

TIMP-1	NULL
inhibition	NULL
of	NULL
apoptosis	NULL
provides	NULL
a	NULL
possible	NULL
biological	NULL
basis	NULL
for	NULL
the	NULL
apparently	NULL
paradoxical	NULL
negative	NULL
prognosis	NULL
that	NULL
is	NULL
associated	NULL
with	NULL
increased	NULL
TIMP-1	NULL
expression	NULL
in	NULL
many	NULL
solid	NULL
tumors	NULL
(	NULL
9	NULL
,	NULL
36-40	NULL
)	NULL
.	NULL

If	NULL
TIMP-1	NULL
's	NULL
sole	NULL
biological	NULL
activity	NULL
is	NULL
inhibition	NULL
of	NULL
MMPs	NULL
,	NULL
elevated	NULL
TIMP-1	NULL
levels	NULL
would	NULL
be	NULL
expected	NULL
to	NULL
decrease	NULL
invasion	NULL
and	NULL
metastasis	NULL
,	NULL
thereby	NULL
improving	NULL
progno-sis	NULL
.	NULL

However	NULL
,	NULL
TIMP-1	NULL
levels	NULL
are	NULL
elevated	NULL
in	NULL
human	NULL
colorectal	NULL
cancer	NULL
compared	NULL
with	NULL
normal	NULL
colonic	NULL
tissue	NULL
(	NULL
37	NULL
)	NULL
,	NULL
and	NULL
higher	NULL
TIMP-1	NULL
levels	NULL
are	NULL
associated	NULL
with	NULL
lymph	NULL
node	NULL
and	NULL
distant	NULL
mestastasis	NULL
in	NULL
this	NULL
disease	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Increased	NULL
TIMP-1	NULL
is	NULL
an	NULL
important	NULL
negative	NULL
prognostic	NULL
indicator	NULL
in	NULL
gastric	NULL
carcinoma	NULL
(	NULL
9	NULL
)	NULL
.	NULL

In	NULL
patients	NULL
with	NULL
non-small	NULL
cell	NULL
lung	NULL
carcinoma	NULL
,	NULL
a	NULL
significant	NULL
decrease	NULL
in	NULL
survival	NULL
was	NULL
observed	NULL
with	NULL
high	NULL
TIMP-1	NULL
expression	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Enhanced	NULL
levels	NULL
of	NULL
TIMP-1	NULL
expression	NULL
in	NULL
breast	NULL
cancer	NULL
are	NULL
associated	NULL
with	NULL
distant	NULL
metastasis	NULL
and	NULL
poor	NULL
outcome	NULL
(	NULL
36	NULL
,	NULL
40	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
serum	NULL
TIMP-1	NULL
levels	NULL
are	NULL
significantly	NULL
increased	NULL
in	NULL
patients	NULL
with	NULL
pancreatic	NULL
carcinoma	NULL
,	NULL
and	NULL
when	NULL
detected	NULL
in	NULL
combination	NULL
with	NULL
CA19-9	NULL
or	NULL
carcinoembryonic	NULL
anti	NULL
2008	NULL
-	NULL
Guedez	NULL
et	NULL
al	NULL
.	NULL

gen	NULL
,	NULL
are	NULL
a	NULL
highly	NULL
specific	NULL
marker	NULL
for	NULL
disease	NULL
(	NULL
41	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
have	NULL
led	NULL
many	NULL
of	NULL
these	NULL
authors	NULL
to	NULL
propose	NULL
independently	NULL
that	NULL
TIMP-1	NULL
is	NULL
a	NULL
growth	NULL
and/or	NULL
survival	NULL
factor	NULL
(	NULL
9	NULL
,	NULL
36	NULL
,	NULL
38	NULL
,	NULL
39	NULL
)	NULL
.	NULL

While	NULL
we	NULL
realize	NULL
that	NULL
these	NULL
observations	NULL
are	NULL
not	NULL
evidence	NULL
of	NULL
a	NULL
direct	NULL
antiapoptotic	NULL
effect	NULL
,	NULL
they	NULL
are	NULL
highly	NULL
suggestive	NULL
that	NULL
TIMP-1	NULL
may	NULL
exert	NULL
growth	NULL
promoting	NULL
activity	NULL
in	NULL
multiple	NULL
sys-tems	NULL
.	NULL

TIMP-2	NULL
's	NULL
failure	NULL
to	NULL
inhibit	NULL
PCD	NULL
in	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
lines	NULL
is	NULL
in	NULL
contrast	NULL
to	NULL
its	NULL
observed	NULL
antiapoptotic	NULL
activity	NULL
in	NULL
melanoma	NULL
cell	NULL
lines	NULL
(	NULL
32	NULL
)	NULL
and	NULL
suggests	NULL
that	NULL
the	NULL
effects	NULL
of	NULL
various	NULL
TIMPs	NULL
on	NULL
apoptosis	NULL
may	NULL
be	NULL
tissue	NULL
specific	NULL
.	NULL

This	NULL
is	NULL
further	NULL
supported	NULL
by	NULL
our	NULL
observation	NULL
that	NULL
TIMP-1	NULL
inhibited	NULL
apoptosis	NULL
in	NULL
normal	NULL
tonsillar	NULL
B	NULL
cells	NULL
but	NULL
not	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
TIMP-1	NULL
's	NULL
inhibition	NULL
of	NULL
apoptosis	NULL
may	NULL
be	NULL
dependent	NULL
upon	NULL
stage	NULL
of	NULL
differentiation	NULL
and	NULL
or	NULL
cellular	NULL
millieu	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
reported	NULL
that	NULL
TIMP-1	NULL
is	NULL
expressed	NULL
in	NULL
isolated	NULL
tonsillar	NULL
B	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
peripheral	NULL
blood	NULL
B	NULL
cells	NULL
.	NULL

Moreover	NULL
,	NULL
maintaining	NULL
isolated	NULL
tonsillar	NULL
B	NULL
cells	NULL
in	NULL
culture	NULL
resulted	NULL
in	NULL
decreased	NULL
TIMP-1	NULL
expression	NULL
over	NULL
time	NULL
compared	NULL
with	NULL
freshly	NULL
isolated	NULL
tonsillar	NULL
B	NULL
cells	NULL
,	NULL
with	NULL
a	NULL
significant	NULL
decrease	NULL
in	NULL
TIMP-1	NULL
expression	NULL
noted	NULL
by	NULL
4	NULL
h	NULL
(	NULL
7	NULL
)	NULL
.	NULL

In	NULL
the	NULL
current	NULL
study	NULL
,	NULL
TIMP-1	NULL
inhibited	NULL
PCD	NULL
in	NULL
tonsillar	NULL
germinal	NULL
center	NULL
B	NULL
cells	NULL
and	NULL
Burkitt	NULL
's	NULL
lymphomas	NULL
,	NULL
which	NULL
are	NULL
also	NULL
germinal	NULL
center	NULL
in	NULL
origin	NULL
.	NULL

Thus	NULL
TIMP-1	NULL
protection	NULL
from	NULL
PCD	NULL
may	NULL
be	NULL
dependent	NULL
upon	NULL
B	NULL
cell	NULL
differentiation	NULL
.	NULL

Germinal	NULL
center	NULL
tonsillar	NULL
B	NULL
cells	NULL
cultured	NULL
for	NULL
16	NULL
h	NULL
in	NULL
serum-free	NULL
media	NULL
undergo	NULL
apoptosis	NULL
,	NULL
an	NULL
event	NULL
that	NULL
is	NULL
not	NULL
unexpected	NULL
in	NULL
view	NULL
of	NULL
their	NULL
significantly	NULL
decreased	NULL
TIMP-1	NULL
expression	NULL
(	NULL
7	NULL
)	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
rTIMP-1	NULL
to	NULL
protect	NULL
these	NULL
B	NULL
cells	NULL
from	NULL
apoptosis	NULL
indicates	NULL
that	NULL
germinal	NULL
center	NULL
B	NULL
cells	NULL
are	NULL
sensitive	NULL
to	NULL
this	NULL
biological	NULL
activity	NULL
of	NULL
TIMP-1	NULL
,	NULL
while	NULL
the	NULL
proper	NULL
cellular	NULL
milieu	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
germinal	NULL
center	NULL
extracellular	NULL
matrix	NULL
and	NULL
support	NULL
cells	NULL
)	NULL
appears	NULL
necessary	NULL
to	NULL
maintain	NULL
TIMP-1	NULL
expression	NULL
.	NULL

The	NULL
growth	NULL
promoting	NULL
effects	NULL
of	NULL
TIMP-1	NULL
do	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
due	NULL
to	NULL
withdrawal	NULL
from	NULL
cell	NULL
cycle	NULL
,	NULL
as	NULL
has	NULL
been	NULL
observed	NULL
for	NULL
the	NULL
survival	NULL
activity	NULL
of	NULL
the	NULL
ECM	NULL
(	NULL
42	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
TIMP-1-JD38	NULL
cells	NULL
cultured	NULL
in	NULL
serum-deprived	NULL
conditions	NULL
continued	NULL
cell	NULL
cycle	NULL
for	NULL
extended	NULL
periods	NULL
of	NULL
time	NULL
.	NULL

These	NULL
results	NULL
support	NULL
TIMP-1	NULL
as	NULL
an	NULL
antiapoptotic	NULL
factor	NULL
that	NULL
inhibits	NULL
PCD	NULL
while	NULL
allowing	NULL
cell	NULL
growth	NULL
in	NULL
stress	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
TIMP-1	NULL
is	NULL
secreted	NULL
by	NULL
these	NULL
cell	NULL
lines	NULL
and	NULL
binds	NULL
to	NULL
the	NULL
cell	NULL
surface	NULL
in	NULL
combination	NULL
with	NULL
the	NULL
demonstration	NULL
that	NULL
neutralization	NULL
of	NULL
secreted	NULL
TIMP-1	NULL
reverses	NULL
suppression	NULL
of	NULL
apoptosis	NULL
,	NULL
suggests	NULL
that	NULL
TIMP-1	NULL
acts	NULL
through	NULL
a	NULL
receptor-mediated	NULL
autocrine	NULL
loop	NULL
.	NULL

Other	NULL
investigators	NULL
(	NULL
12	NULL
,	NULL
13	NULL
,	NULL
22	NULL
)	NULL
have	NULL
postulated	NULL
the	NULL
presence	NULL
of	NULL
such	NULL
a	NULL
receptor	NULL
.	NULL

Studies	NULL
in	NULL
our	NULL
laboratory	NULL
are	NULL
underway	NULL
to	NULL
isolate	NULL
and	NULL
characterize	NULL
this	NULL
receptor	NULL
.	NULL

The	NULL
central	NULL
role	NULL
of	NULL
apoptosis	NULL
in	NULL
the	NULL
homeostasis	NULL
of	NULL
lymphoid	NULL
tissues	NULL
is	NULL
now	NULL
widely	NULL
acknowledged	NULL
.	NULL

In	NULL
lymphocytes	NULL
there	NULL
are	NULL
at	NULL
least	NULL
two	NULL
independent	NULL
pathways	NULL
for	NULL
initiation	NULL
of	NULL
PCD	NULL
:	NULL
the	NULL
tumor	NULL
necrosis	NULL
(	NULL
TNF	NULL
)	NULL
/nerve	NULL
growth	NULL
factor	NULL
(	NULL
NGF	NULL
)	NULL
receptor	NULL
family	NULL
pathway	NULL
(	NULL
involved	NULL
in	NULL
numerous	NULL
functions	NULL
limiting	NULL
immunoresponses	NULL
and	NULL
T	NULL
cell	NULL
cytotoxity	NULL
)	NULL
,	NULL
and	NULL
the	NULL
Bcl-2	NULL
family-dependent	NULL
pathway	NULL
,	NULL
initiated	NULL
by	NULL
factors	NULL
such	NULL
as	NULL
irradia-tion	NULL
,	NULL
cytotoxic	NULL
drugs	NULL
,	NULL
and	NULL
serum	NULL
deprivation	NULL
(	NULL
43-46	NULL
)	NULL
.	NULL

Except	NULL
for	NULL
Bcl-X	NULL
;	NULL
,	NULL
,	NULL
Bcel-2	NULL
family	NULL
members	NULL
have	NULL
not	NULL
been	NULL
shown	NULL
to	NULL
directly	NULL
alter	NULL
CD95/Fas	NULL
pathway	NULL
in	NULL
lymphocytes	NULL
(	NULL
45	NULL
,	NULL
46	NULL
)	NULL
.	NULL

Results	NULL
of	NULL
the	NULL
present	NULL
study	NULL
demonstrate	NULL
that	NULL
TIMP-1	NULL
protects	NULL
B	NULL
cells	NULL
from	NULL
apoptosis	NULL
induced	NULL
by	NULL
both	NULL
Bcl-2-dependent	NULL
pathways	NULL
(	NULL
serum	NULL
starvation	NULL
and	NULL
y-radiation	NULL
)	NULL
and	NULL
Bcl-2	NULL
independent	NULL
ones	NULL
such	NULL
as	NULL
Fas	NULL
(	NULL
43-45	NULL
)	NULL
.	NULL

Most	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
lines	NULL
are	NULL
prone	NULL
to	NULL
apoptosis	NULL
and	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
highly	NULL
sensitive	NULL
to	NULL
cold	NULL
shock	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Although	NULL
factors	NULL
implicated	NULL
in	NULL
the	NULL
control	NULL
of	NULL
this	NULL
pathway	NULL
are	NULL
yet	NULL
to	NULL
be	NULL
described	NULL
,	NULL
some	NULL
reports	NULL
suggest	NULL
that	NULL
Bcl-2	NULL
is	NULL
not	NULL
one	NULL
of	NULL
them	NULL
(	NULL
19	NULL
,	NULL
47	NULL
)	NULL
,	NULL
and	NULL
this	NULL
may	NULL
be	NULL
a	NULL
third	NULL
pathway	NULL
for	NULL
induction	NULL
of	NULL
PCD	NULL
that	NULL
TIMP-1	NULL
can	NULL
also	NULL
protect	NULL
against	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
TIMP-1	NULL
did	NULL
not	NULL
affect	NULL
Bel-2	NULL
or	NULL
CD95	NULL
expression	NULL
.	NULL

However	NULL
Bcel-X	NULL
;	NULL
,	NULL
is	NULL
upregulated	NULL
in	NULL
the	NULL
TIMP-1-JD38	NULL
cell	NULL
clones	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
TIMP-1	NULL
protective	NULL
effect	NULL
might	NULL
be	NULL
in	NULL
part	NULL
mediated	NULL
through	NULL
induction	NULL
of	NULL
Bcl-X	NULL
;	NULL
,	NULL
.	NULL

Bel-X	NULL
;	NULL
,	NULL
is	NULL
known	NULL
to	NULL
not	NULL
only	NULL
overlap	NULL
with	NULL
Bel-2	NULL
in	NULL
protection	NULL
from	NULL
apoptosis	NULL
but	NULL
also	NULL
exerts	NULL
its	NULL
protective	NULL
effect	NULL
in	NULL
pathways	NULL
not	NULL
controlled	NULL
by	NULL
Bel-2	NULL
,	NULL
such	NULL
as	NULL
the	NULL
Fas/TNF	NULL
pathway	NULL
(	NULL
45	NULL
,	NULL
46	NULL
,	NULL
48	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
B	NULL
cell	NULL
studies	NULL
showing	NULL
induction	NULL
of	NULL
antiapoptotic	NULL
proteins	NULL
by	NULL
NF-kB	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
,	NULL
the	NULL
present	NULL
study	NULL
demonstrates	NULL
upregulation	NULL
of	NULL
the	NULL
inhibitor	NULL
IxBa	NULL
(	NULL
48	NULL
)	NULL
in	NULL
TIMP-1-JD38	NULL
clones	NULL
.	NULL

Therefore	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
may	NULL
not	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
antiapoptotic	NULL
proteins	NULL
by	NULL
TIMP-1	NULL
.	NULL

Interestingly	NULL
,	NULL
this	NULL
decreased	NULL
NF-kB	NULL
activity	NULL
is	NULL
also	NULL
supported	NULL
by	NULL
our	NULL
previous	NULL
results	NULL
showing	NULL
downregulation	NULL
of	NULL
immunoglobulin	NULL
expression	NULL
in	NULL
TIMP-1-positive	NULL
cells	NULL
,	NULL
since	NULL
immunoglobulin	NULL
expression	NULL
is	NULL
known	NULL
to	NULL
be	NULL
controlled	NULL
by	NULL
NFB	NULL
(	NULL
49	NULL
)	NULL
.	NULL

Future	NULL
studies	NULL
are	NULL
needed	NULL
to	NULL
conclusively	NULL
determine	NULL
the	NULL
role	NULL
of	NULL
NF-kB	NULL
or	NULL
to	NULL
identify	NULL
other	NULL
transcription	NULL
factors	NULL
involved	NULL
in	NULL
TIMP-1	NULL
's	NULL
antiapoptotic	NULL
effect	NULL
.	NULL

Overall	NULL
,	NULL
this	NULL
study	NULL
supports	NULL
a	NULL
novel	NULL
role	NULL
for	NULL
TIMP-1	NULL
in	NULL
the	NULL
control	NULL
of	NULL
apoptosis	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Results	NULL
discussed	NULL
here	NULL
provide	NULL
a	NULL
biological	NULL
basis	NULL
for	NULL
the	NULL
observed	NULL
negative	NULL
prognosis	NULL
associated	NULL
with	NULL
increased	NULL
TIMP-1	NULL
expression	NULL
in	NULL
non-Hodgkin	NULL
's	NULL
lymphomas	NULL
,	NULL
as	NULL
well	NULL
as	NULL
many	NULL
solid	NULL
tumors	NULL
(	NULL
8-10	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Further	NULL
studies	NULL
are	NULL
indicated	NULL
to	NULL
determine	NULL
if	NULL
TIMP-1	NULL
inhibition	NULL
of	NULL
apoptosis	NULL
in	NULL
the	NULL
tumor	NULL
cells	NULL
alters	NULL
the	NULL
prognosis	NULL
in	NULL
these	NULL
patients	NULL
.	NULL

Acknowledgments	NULL
The	NULL
authors	NULL
thank	NULL
Dr.	NULL
Megan	NULL
Lim	NULL
for	NULL
performing	NULL
the	NULL
reverse	NULL
zymo-graph	NULL
analysis	NULL
,	NULL
Dr.	NULL
Peter	NULL
Brown	NULL
,	NULL
British	NULL
Biotechnology	NULL
,	NULL
Ltd.	NULL
,	NULL
for	NULL
supplying	NULL
BB-94	NULL
,	NULL
Dr.	NULL
Anita	NULL
Yu	NULL
for	NULL
reduced	NULL
and	NULL
alkylated	NULL
TIMP-1	NULL
,	NULL
and	NULL
Dr.	NULL
Kevin	NULL
Gardner	NULL
for	NULL
his	NULL
valuable	NULL
advice	NULL
and	NULL
NF-KB	NULL
antibodies	NULL
.	NULL

References	NULL
1	NULL
.	NULL

McDonnell	NULL
,	NULL
T.J.	NULL
,	NULL
and	NULL
S.J	NULL
.	NULL

Korsmeyer	NULL
.	NULL

1991	NULL
.	NULL

Progression	NULL
from	NULL
lymphoid	NULL
hyperplasia	NULL
to	NULL
high	NULL
grade	NULL
malignant	NULL
lymphoma	NULL
in	NULL
mice	NULL
transgenic	NULL
for	NULL
the	NULL
t	NULL
(	NULL
14	NULL
;	NULL
18	NULL
)	NULL
.	NULL

Nature	NULL
.	NULL

349:254-256	NULL
.	NULL

2	NULL
.	NULL

Cohen	NULL
,	NULL
J.J.	NULL
1991	NULL
.	NULL

Programmed	NULL
cell	NULL
death	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Adv	NULL
.	NULL

Immunol	NULL
.	NULL

50:55-63	NULL
.	NULL

3	NULL
.	NULL

Alexander	NULL
,	NULL
C.M	NULL
.	NULL

,	NULL
E.W	NULL
.	NULL

Howard	NULL
,	NULL
M.J.	NULL
Bissell	NULL
,	NULL
and	NULL
Z.	NULL
Werb	NULL
.	NULL

1996	NULL
.	NULL

Rescue	NULL
of	NULL
mammary	NULL
epithelial	NULL
cell	NULL
apoptosis	NULL
and	NULL
entactin	NULL
degradation	NULL
by	NULL
tissue	NULL
inhibitor	NULL
of	NULL
metalloproteinase-transgene	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

135:1669-1677	NULL
.	NULL

4	NULL
.	NULL

Boudreau	NULL
,	NULL
N.	NULL
,	NULL
C.J	NULL
.	NULL

Sympson	NULL
,	NULL
Z.	NULL
Werb	NULL
,	NULL
and	NULL
M.	NULL
Bissell	NULL
.	NULL

1995	NULL
.	NULL

Suppression	NULL
of	NULL
ICE	NULL
and	NULL
apoptosis	NULL
in	NULL
mammary	NULL
epithelial	NULL
cells	NULL
by	NULL
extracellular	NULL
matrix	NULL
.	NULL

Sci-ence	NULL
.	NULL

267:891-893	NULL
.	NULL

5	NULL
.	NULL

McGeehan	NULL
,	NULL
G.M	NULL
.	NULL

,	NULL
J.D	NULL
.	NULL

Becherer	NULL
,	NULL
R.C	NULL
.	NULL

Bast	NULL
,	NULL
B	NULL
.	NULL

Champion	NULL
,	NULL
K.M	NULL
.	NULL

Con-nolly	NULL
,	NULL
J.G	NULL
.	NULL

Conway	NULL
,	NULL
F.	NULL
Furdon	NULL
,	NULL
S.	NULL
Karp	NULL
,	NULL
S.	NULL
Kidao	NULL
,	NULL
A.B	NULL
.	NULL

McElroy	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
.	NULL

Regulation	NULL
of	NULL
tumor	NULL
necrosis-factor	NULL
alpha	NULL
processing	NULL
by	NULL
metalloproteinase	NULL
in-hibitor	NULL
.	NULL

Nature	NULL
.	NULL

370:558-561	NULL
.	NULL

6	NULL
.	NULL

Tanaka	NULL
,	NULL
M.	NULL
,	NULL
T.	NULL
Suda	NULL
,	NULL
K.	NULL
Haze	NULL
,	NULL
N.	NULL
Nakamura	NULL
,	NULL
N.	NULL
Sato	NULL
,	NULL
F.	NULL
Kimura	NULL
,	NULL
K.	NULL
Mo-toyoshi	NULL
,	NULL
M.	NULL
Mizuki	NULL
,	NULL
S.	NULL
Tagawa	NULL
,	NULL
S.	NULL
Ohga	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
.	NULL

Fas	NULL
ligand	NULL
in	NULL
human	NULL
serum	NULL
.	NULL

Nat	NULL
.	NULL

Med	NULL
.	NULL

2:317-322	NULL
.	NULL

7	NULL
.	NULL

Stetler-Stevenson	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
Mansoor	NULL
,	NULL
M.S	NULL
.	NULL

Lim	NULL
,	NULL
P.	NULL
Fukushima	NULL
,	NULL
J.	NULL
Kehrl	NULL
,	NULL
G.	NULL
Marti	NULL
,	NULL
K.	NULL
Ptaszynski	NULL
,	NULL
J.	NULL
Wang	NULL
,	NULL
and	NULL
W.G	NULL
.	NULL

Stetler-Stevenson	NULL
.	NULL

1997	NULL
.	NULL

Expression	NULL
of	NULL
matrix	NULL
metalloproteinases	NULL
and	NULL
tissue	NULL
inhibitors	NULL
of	NULL
metalloproteinases	NULL
(	NULL
TIMPs	NULL
)	NULL
in	NULL
reactive	NULL
and	NULL
neoplastic	NULL
lymph	NULL
nodes	NULL
.	NULL

Blood	NULL
.	NULL

89:1708-1715	NULL
.	NULL

8	NULL
.	NULL

Kossakowska	NULL
,	NULL
E.E	NULL
.	NULL

,	NULL
S.J	NULL
.	NULL

Urbanski	NULL
,	NULL
and	NULL
D.E	NULL
.	NULL

Edwards	NULL
.	NULL

1991	NULL
.	NULL

Tissue	NULL
inhibitor	NULL
of	NULL
metalloproteinases-1	NULL
(	NULL
TIMP-1	NULL
)	NULL
RNA	NULL
is	NULL
expressed	NULL
at	NULL
elevated	NULL
levels	NULL
in	NULL
malignant	NULL
non-Hodgkin	NULL
's	NULL
lymphomas	NULL
.	NULL

Blood	NULL
.	NULL

77:2474-2481	NULL
.	NULL

9	NULL
.	NULL

Mimori	NULL
,	NULL
K.	NULL
,	NULL
M.	NULL
Mori	NULL
,	NULL
T.	NULL
Shiraishi	NULL
,	NULL
T.	NULL
Fujie	NULL
,	NULL
K.	NULL
Baba	NULL
,	NULL
M.	NULL
Haraguchi	NULL
,	NULL
R.	NULL
Abe	NULL
,	NULL
H.	NULL
Ueo	NULL
,	NULL
and	NULL
T.	NULL
Akiyoshi	NULL
.	NULL

1997	NULL
.	NULL

Clinical	NULL
significance	NULL
of	NULL
tissue	NULL
inhibitor	NULL
of	NULL
metalloproteinase	NULL
expression	NULL
in	NULL
gastric	NULL
carcinoma	NULL
.	NULL

Br	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
.	NULL

76:531-536	NULL
.	NULL

10	NULL
.	NULL

Mansoor	NULL
,	NULL
A.	NULL
,	NULL
B.	NULL
Birkedal-Hansen	NULL
,	NULL
M.S	NULL
.	NULL

Lim	NULL
,	NULL
L.	NULL
Guedez	NULL
,	NULL
W.G	NULL
.	NULL

Stetler-Stevenson	NULL
,	NULL
and	NULL
M.	NULL
Stetler-Stevenson	NULL
.	NULL

1997	NULL
.	NULL

TIMP-1	NULL
expression	NULL
correlates	NULL
with	NULL
histologic	NULL
grade	NULL
in	NULL
B-cell	NULL
lymphomas	NULL
.	NULL

Mod	NULL
.	NULL

Pathol	NULL
.	NULL

10:130a	NULL
.	NULL

(	NULL
Abstr	NULL
.	NULL
)	NULL

11	NULL
.	NULL

Stetler-Stevenson	NULL
,	NULL
W.G	NULL
.	NULL

,	NULL
N.	NULL
Bersh	NULL
,	NULL
and	NULL
D.W.	NULL
Golde	NULL
.	NULL

1992	NULL
.	NULL

Tissue	NULL
inhibitor	NULL
of	NULL
metalloproteinase-2	NULL
(	NULL
TIMP-2	NULL
)	NULL
has	NULL
erythroid	NULL
potentiating	NULL
activity	NULL
.	NULL

FEBS	NULL
.	NULL

296:231-234	NULL
.	NULL

12	NULL
.	NULL

Chesler	NULL
,	NULL
L.	NULL
,	NULL
D.W.	NULL
Golde	NULL
,	NULL
N.	NULL
Bersch	NULL
,	NULL
and	NULL
M.	NULL
D.	NULL
Johnson	NULL
.	NULL

1995	NULL
.	NULL

Metalloproteinase	NULL
inhibition	NULL
and	NULL
erythroid	NULL
potentiating	NULL
are	NULL
independent	NULL
activities	NULL
of	NULL
tissue	NULL
inhibitor	NULL
of	NULL
metalloproteinase-1	NULL
.	NULL

Blood	NULL
.	NULL

86:4506-4515	NULL
.	NULL

13	NULL
.	NULL

Hayakawa	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
Yamashita	NULL
,	NULL
K.	NULL
Tanzawa	NULL
,	NULL
E.	NULL
Uchijima	NULL
,	NULL
and	NULL
K.	NULL
Iwata	NULL
.	NULL

1992	NULL
.	NULL

Growth-promoting	NULL
activity	NULL
of	NULL
tissue	NULL
inhibitor	NULL
of	NULL
metalloproteinases-1	NULL
(	NULL
TIMP-1	NULL
)	NULL
for	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
cells	NULL
,	NULL
a	NULL
possible	NULL
new	NULL
growth	NULL
factor	NULL
in	NULL
serum	NULL
.	NULL

FEBS	NULL
Lett	NULL
.	NULL

298:29-32	NULL
.	NULL

14	NULL
.	NULL

Anwar	NULL
,	NULL
N.	NULL
,	NULL
D.W.	NULL
Kingma	NULL
,	NULL
A.R	NULL
.	NULL

Bloch	NULL
,	NULL
R.	NULL
Mourad	NULL
,	NULL
M.	NULL
Raffeld	NULL
,	NULL
J.	NULL
Frank-lin	NULL
,	NULL
I.	NULL
Magrath	NULL
,	NULL
N.	NULL
Bolkainey	NULL
,	NULL
and	NULL
E.S	NULL
.	NULL

Jaffee	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
investigation	NULL
of	NULL
Ep-stein-Barr-virus	NULL
sequences	NULL
in	NULL
41	NULL
cases	NULL
of	NULL
Burkitt	NULL
's	NULL
lymphomas	NULL
from	NULL
Egypt	NULL
:	NULL
epi-mediologic	NULL
correlation	NULL
.	NULL

Cancer	NULL
.	NULL

76:1241-1252	NULL
.	NULL

15	NULL
.	NULL

O'Connor	NULL
,	NULL
P.M.	NULL
,	NULL
J.	NULL
Jakman	NULL
,	NULL
D.	NULL
Jondle	NULL
,	NULL
K.	NULL
Bhatia	NULL
,	NULL
I.	NULL
Magrath	NULL
,	NULL
and	NULL
K.W	NULL
.	NULL

Khon	NULL
.	NULL

1993	NULL
.	NULL

Role	NULL
of	NULL
the	NULL
p53	NULL
tumor	NULL
suppresser	NULL
gene	NULL
in	NULL
cell	NULL
cycle	NULL
arrest	NULL
and	NULL
radio-sensitivity	NULL
of	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
lines	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

53:4776-4780	NULL
.	NULL

16	NULL
.	NULL

Gaidano	NULL
,	NULL
G.	NULL
,	NULL
P.	NULL
Ballerini	NULL
,	NULL
J.Z	NULL
.	NULL

Gong	NULL
,	NULL
G.	NULL
Inghiriami	NULL
,	NULL
A.	NULL
Neri	NULL
,	NULL
E.W	NULL
.	NULL

New-comb	NULL
,	NULL
I.	NULL
Magrath	NULL
,	NULL
D.M	NULL
.	NULL

Knowels	NULL
,	NULL
and	NULL
R.	NULL
Dalla-Favera	NULL
.	NULL

1991	NULL
.	NULL

P53	NULL
mutations	NULL
in	NULL
human	NULL
lymphoid	NULL
malignancies	NULL
:	NULL
association	NULL
with	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
and	NULL
chronic	NULL
lymphocytic	NULL
leukemia	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

88:5413-5417	NULL
.	NULL

17	NULL
.	NULL

Bhatia	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Fan	NULL
,	NULL
G.	NULL
Spancler	NULL
,	NULL
M.	NULL
Weintraub	NULL
,	NULL
P.M.	NULL
O'Connor	NULL
,	NULL
J.G	NULL
.	NULL

Judde	NULL
,	NULL
and	NULL
I.	NULL
Magrath	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
mutant	NULL
p21	NULL
cyclin-dependent	NULL
kinase	NULL
inhibitor	NULL
isolated	NULL
from	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

55:1431-1435	NULL
.	NULL

18	NULL
.	NULL

Oliver	NULL
,	NULL
G.W	NULL
.	NULL

,	NULL
J.D	NULL
.	NULL

Leferson	NULL
,	NULL
W.G	NULL
.	NULL

Stetler-Stevenson	NULL
,	NULL
and	NULL
D.E	NULL
.	NULL

Kleiner	NULL
.	NULL

1996	NULL
.	NULL

Quantitative	NULL
reverse	NULL
zymography	NULL
:	NULL
analysis	NULL
using	NULL
gelatinase	NULL
A	NULL
and	NULL
B	NULL
reverse	NULL
zymograms	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

244:161-163	NULL
.	NULL

19	NULL
.	NULL

Gregory	NULL
,	NULL
C.D	NULL
.	NULL

,	NULL
and	NULL
A.E	NULL
.	NULL

Milner	NULL
.	NULL

1994	NULL
.	NULL

Regulation	NULL
of	NULL
cell	NULL
survival	NULL
in	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
:	NULL
implications	NULL
from	NULL
studies	NULL
of	NULL
apoptosis	NULL
following	NULL
cold-shock	NULL
treatment	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
.	NULL

57:419-426	NULL
.	NULL

20	NULL
.	NULL

Dive	NULL
,	NULL
C.	NULL
,	NULL
C.D	NULL
.	NULL

Gregory	NULL
,	NULL
D.J	NULL
.	NULL

Phipps	NULL
,	NULL
D.L	NULL
.	NULL

Evans	NULL
,	NULL
A.E	NULL
.	NULL

Milner	NULL
,	NULL
and	NULL
A.H.	NULL
Wyllie	NULL
.	NULL

1992	NULL
.	NULL

Analysis	NULL
and	NULL
discrimination	NULL
of	NULL
necrosis	NULL
and	NULL
apoptosis	NULL
(	NULL
pro-grammed	NULL
cell	NULL
death	NULL
)	NULL
by	NULL
multiparameter	NULL
flow	NULL
cytometry	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
.	NULL

1133:275-285	NULL
.	NULL

21	NULL
.	NULL

Markwitz	NULL
,	NULL
D.	NULL
,	NULL
S.	NULL
Goff	NULL
,	NULL
and	NULL
A	NULL
.	NULL

Bank	NULL
.	NULL

1988	NULL
.	NULL

Construction	NULL
and	NULL
use	NULL
of	NULL
a	NULL
safe	NULL
and	NULL
efficient	NULL
amphotropic	NULL
packaging	NULL
cell	NULL
line	NULL
.	NULL

Virology	NULL
.	NULL

167:400-406	NULL
.	NULL

22	NULL
.	NULL

Bertaux	NULL
,	NULL
B.	NULL
,	NULL
W.	NULL
Hornebeck	NULL
,	NULL
A.Z	NULL
.	NULL

Eisen	NULL
,	NULL
and	NULL
L.	NULL
Dubertret	NULL
.	NULL

1991	NULL
.	NULL

Growth	NULL
stimulation	NULL
of	NULL
human	NULL
keratinocytes	NULL
by	NULL
tissue	NULL
inhibitor	NULL
of	NULL
metalloproteinases	NULL
.	NULL

J	NULL
.	NULL

Invest	NULL
.	NULL

Dermatol	NULL
.	NULL

97:679-685	NULL
.	NULL

23	NULL
.	NULL

Hayakawa	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
Yamashita	NULL
,	NULL
E.	NULL
Ohuchi	NULL
,	NULL
and	NULL
A.	NULL
Shinagawa	NULL
.	NULL

1994	NULL
.	NULL

Cell	NULL
growth	NULL
activity	NULL
of	NULL
tissue	NULL
inhibitor	NULL
of	NULL
metalloproteinases-2	NULL
(	NULL
TIMP-2	NULL
)	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Sci	NULL
.	NULL

107:2373-2379	NULL
.	NULL

24	NULL
.	NULL

Rothstein	NULL
,	NULL
T.L	NULL
.	NULL

1996	NULL
.	NULL

Signals	NULL
and	NULL
susceptibility	NULL
to	NULL
programmed	NULL
cell	NULL
death	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

8:362-371	NULL
.	NULL

25	NULL
.	NULL

Guedez	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
J.	NULL
Zucali	NULL
.	NULL

1996	NULL
.	NULL

Bleomycin-induced	NULL
differentiation	NULL
of	NULL
bel-2-transfected	NULL
U-937	NULL
leukemia	NULL
cells	NULL
.	NULL

Cell	NULL
Growth	NULL
Differ	NULL
.	NULL

7:1625-1631	NULL
.	NULL

26	NULL
.	NULL

Korsmeyer	NULL
,	NULL
S.J	NULL
.	NULL

1992	NULL
.	NULL

Bel-2	NULL
:	NULL
an	NULL
antidote	NULL
to	NULL
programmed	NULL
cell	NULL
death	NULL
.	NULL

Cancer	NULL
Surv	NULL
.	NULL

15:105-118	NULL
.	NULL

27	NULL
.	NULL

Bodrug	NULL
,	NULL
S.E	NULL
.	NULL

,	NULL
C.	NULL
Aime-Sempe	NULL
,	NULL
T.	NULL
Sato	NULL
,	NULL
S.	NULL
Krajewski	NULL
,	NULL
M.	NULL
Hanada	NULL
,	NULL
and	NULL
J.C.	NULL
Reed	NULL
.	NULL

1995	NULL
.	NULL

Biochemical	NULL
and	NULL
functional	NULL
comparisons	NULL
of	NULL
Mcl-1	NULL
and	NULL
Bcl-2	NULL
proteins	NULL
:	NULL
evidence	NULL
of	NULL
a	NULL
novel	NULL
mechanism	NULL
of	NULL
regulating	NULL
Bcl-2	NULL
family	NULL
function	NULL
.	NULL

Cell	NULL
Death	NULL
Differ	NULL
.	NULL

2:173-182	NULL
.	NULL

28	NULL
.	NULL

Baker	NULL
,	NULL
S.J	NULL
.	NULL

,	NULL
and	NULL
E.P	NULL
.	NULL

Reddy	NULL
.	NULL

1996	NULL
.	NULL

Transducers	NULL
of	NULL
life	NULL
or	NULL
death	NULL
:	NULL
TNF	NULL
receptor	NULL
superfamily	NULL
and	NULL
associated	NULL
proteins	NULL
.	NULL

Oncogene	NULL
.	NULL

12:1-9	NULL
.	NULL

29	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.A	NULL
.	NULL

,	NULL
and	NULL
T.	NULL
Henkel	NULL
.	NULL

1994	NULL
.	NULL

Function	NULL
and	NULL
activation	NULL
of	NULL
NF-kB	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:141-179	NULL
.	NULL

30	NULL
.	NULL

Hsing	NULL
,	NULL
Y.	NULL
,	NULL
B.S	NULL
.	NULL

Hostager	NULL
,	NULL
and	NULL
G.A	NULL
.	NULL

Bishop	NULL
.	NULL

1997	NULL
.	NULL

Characterization	NULL
of	NULL
CD40	NULL
signaling	NULL
determinants	NULL
regulating	NULL
nuclear	NULL
factor-kB	NULL
activation	NULL
in	NULL
B	NULL
cells	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:4898-4906	NULL
.	NULL

31	NULL
.	NULL

Guedez	NULL
,	NULL
L.	NULL
,	NULL
M.S	NULL
.	NULL

Lim	NULL
,	NULL
and	NULL
W.G	NULL
.	NULL

Stetler-Stevenson	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
role	NULL
of	NULL
metalloproteinases	NULL
and	NULL
their	NULL
inhibitors	NULL
in	NULL
hematological	NULL
disorders	NULL
.	NULL

Crit	NULL
.	NULL

Rev	NULL
.	NULL

Oncol	NULL
.	NULL

7:205-225	NULL
.	NULL

32	NULL
.	NULL

Valente	NULL
,	NULL
P.	NULL
,	NULL
G.	NULL
Fassina	NULL
,	NULL
A.	NULL
Melchori	NULL
,	NULL
L.	NULL
Masiello	NULL
,	NULL
M.	NULL
Cilli	NULL
,	NULL
A.	NULL
Vacca	NULL
,	NULL
M.	NULL
Onisto	NULL
,	NULL
L.	NULL
Santi	NULL
,	NULL
W.G	NULL
.	NULL

Stetler-Stevenson	NULL
,	NULL
and	NULL
A.	NULL
Albini	NULL
.	NULL

1998	NULL
.	NULL

TIMP-2	NULL
overexpression	NULL
reduces	NULL
invasion	NULL
and	NULL
angiogenesis	NULL
and	NULL
protects	NULL
B16F10	NULL
melanoma	NULL
cells	NULL
from	NULL
apoptosis	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
.	NULL

75:246-253	NULL
.	NULL

33	NULL
.	NULL

Baker	NULL
,	NULL
A.H.	NULL
,	NULL
A.B	NULL
.	NULL

Zaltsman	NULL
,	NULL
S.I	NULL
.	NULL

George	NULL
,	NULL
and	NULL
A.C.	NULL
Newby	NULL
.	NULL

1998	NULL
.	NULL

Divergent	NULL
effects	NULL
of	NULL
tissue	NULL
inhibitors	NULL
of	NULL
metalloproteinase-1	NULL
,	NULL
-2	NULL
,	NULL
or	NULL
-3	NULL
overexpression	NULL
on	NULL
rat	NULL
vascular	NULL
smooth	NULL
muscle	NULL
cell	NULL
invasion	NULL
,	NULL
proliferation	NULL
,	NULL
and	NULL
death	NULL
in	NULL
vitro-TIMP-3	NULL
promotes	NULL
apoptosis	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

101:1478-1487	NULL
.	NULL

34	NULL
.	NULL

DiGirolamo	NULL
,	NULL
N.	NULL
,	NULL
N.	NULL
Tedla	NULL
,	NULL
A.	NULL
Lloyd	NULL
,	NULL
and	NULL
D.	NULL
Wakefield	NULL
.	NULL

1998	NULL
.	NULL

Expression	NULL
of	NULL
matrix	NULL
metalloproteinases	NULL
by	NULL
human	NULL
plasma	NULL
cells	NULL
and	NULL
B	NULL
lymphocytes	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

28:1773-1784	NULL
.	NULL

35	NULL
.	NULL

Guedez	NULL
,	NULL
L.	NULL
,	NULL
L.	NULL
Courtemanch	NULL
,	NULL
and	NULL
M.	NULL
Stetler-Stevenson	NULL
.	NULL

1998	NULL
.	NULL

Tissue	NULL
inhibitor	NULL
of	NULL
metalloproteinase	NULL
(	NULL
TIMP	NULL
)	NULL
-1	NULL
induces	NULL
differentiation	NULL
and	NULL
an	NULL
anti-apop-totic	NULL
phenotype	NULL
in	NULL
germinal	NULL
center	NULL
B-cells	NULL
.	NULL

Blood	NULL
.	NULL

In	NULL
press	NULL
.	NULL

36	NULL
.	NULL

Ree	NULL
,	NULL
A.H.	NULL
,	NULL
V.	NULL
A.	NULL
Florenes	NULL
,	NULL
J.P.	NULL
Berg	NULL
,	NULL
G.M	NULL
.	NULL

Maelandsmo	NULL
,	NULL
J.M	NULL
.	NULL

Nestland	NULL
,	NULL
and	NULL
O.	NULL
Fostad	NULL
.	NULL

1997	NULL
.	NULL

High	NULL
levels	NULL
of	NULL
messenger-RNAs	NULL
for	NULL
tissue	NULL
inhibitors	NULL
of	NULL
metalloproteinases	NULL
(	NULL
TIMP-1	NULL
and	NULL
TIMP-2	NULL
)	NULL
in	NULL
primary	NULL
breast	NULL
carcinomas	NULL
are	NULL
associated	NULL
with	NULL
development	NULL
of	NULL
distant	NULL
metastasis	NULL
.	NULL

Clin	NULL
.	NULL

Cancer	NULL
.	NULL

Res	NULL
.	NULL

3:1623-1628	NULL
.	NULL

TIMP-1	NULL
Suppression	NULL
of	NULL
Programmed	NULL
Cell	NULL
Death	NULL
in	NULL
B	NULL
Cells	NULL
_	NULL
2009	NULL
37	NULL
.	NULL

Stetler-Stevenson	NULL
,	NULL
W.G	NULL
.	NULL

,	NULL
P.D	NULL
.	NULL

Brown	NULL
,	NULL
M.	NULL
Onisto	NULL
,	NULL
A.T.	NULL
Levy	NULL
,	NULL
and	NULL
L.A.	NULL
Liotta	NULL
.	NULL

1990	NULL
.	NULL

Tissue	NULL
inhibitor	NULL
of	NULL
metalloproteinase-2	NULL
(	NULL
TIMP-2	NULL
)	NULL
mRNA	NULL
expression	NULL
in	NULL
tumor	NULL
cell	NULL
lines	NULL
and	NULL
human	NULL
tumor	NULL
tissues	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265:13933-13938	NULL
.	NULL

38	NULL
.	NULL

Zeng	NULL
,	NULL
Z.	NULL
,	NULL
A.M.	NULL
Cohen	NULL
,	NULL
Z.	NULL
Zhang	NULL
,	NULL
W.G	NULL
.	NULL

Stetler-Stevenson	NULL
,	NULL
and	NULL
J.G	NULL
.	NULL

Guillem	NULL
.	NULL

1995	NULL
.	NULL

Elevated	NULL
tissue	NULL
inhibitor	NULL
of	NULL
metalloproteinase-1	NULL
RNA	NULL
in	NULL
colorectal	NULL
cancer	NULL
stroma	NULL
correlates	NULL
with	NULL
lymph	NULL
node	NULL
and	NULL
distant	NULL
metastases	NULL
.	NULL

Clin	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

1:899-906	NULL
.	NULL

39	NULL
.	NULL

Fong	NULL
,	NULL
K.M	NULL
.	NULL

,	NULL
Y.	NULL
Kida	NULL
,	NULL
P.V	NULL
.	NULL

Zimmerman	NULL
,	NULL
and	NULL
P.J	NULL
.	NULL

Smith	NULL
.	NULL

1996	NULL
.	NULL

TIMP-1	NULL
and	NULL
adverse	NULL
prognosis	NULL
in	NULL
non-small	NULL
cell	NULL
lung	NULL
cancer	NULL
.	NULL

Clin	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

2:1369-1372	NULL
.	NULL

40	NULL
.	NULL

McCarthy	NULL
,	NULL
K.	NULL
,	NULL
G.	NULL
Maguire	NULL
,	NULL
G.	NULL
McGreal	NULL
,	NULL
E.	NULL
McDermott	NULL
,	NULL
N.	NULL
O'Higgins	NULL
,	NULL
and	NULL
M.J.	NULL
Duffy	NULL
.	NULL

1998	NULL
.	NULL

High	NULL
levels	NULL
of	NULL
TIMP-1	NULL
predict	NULL
poor	NULL
outcome	NULL
in	NULL
patients	NULL
with	NULL
breast	NULL
cancer	NULL
.	NULL

Br	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
.	NULL

78:41-41	NULL
.	NULL

41	NULL
.	NULL

Zhou	NULL
,	NULL
W.	NULL
,	NULL
L.J	NULL
.	NULL

Sokoll	NULL
,	NULL
D.J	NULL
.	NULL

Bruzek	NULL
,	NULL
V.E	NULL
.	NULL

Velculescu	NULL
,	NULL
$	NULL
.B	NULL
.	NULL

Goldin	NULL
,	NULL
RH	NULL
.	NULL

Hruban	NULL
,	NULL
S.E	NULL
.	NULL

Kern	NULL
,	NULL
S.R	NULL
.	NULL

Hamilton	NULL
,	NULL
D.W.	NULL
Chan	NULL
,	NULL
B.	NULL
Volgelstein	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
.	NULL

Identifying	NULL
markers	NULL
for	NULL
pancreatic	NULL
cancer	NULL
by	NULL
gene	NULL
expression	NULL
analysis	NULL
.	NULL

Cancer	NULL
Epidemiol	NULL
.	NULL

Biomarkers	NULL
Prev	NULL
.	NULL

7:109-112	NULL
.	NULL

42	NULL
.	NULL

Wu	NULL
,	NULL
R.C	NULL
.	NULL

,	NULL
and	NULL
A.H.	NULL
Schonthal	NULL
.	NULL

1997	NULL
.	NULL

Activation	NULL
of	NULL
p53-p21wafl	NULL
pathway	NULL
in	NULL
response	NULL
to	NULL
disruption	NULL
of	NULL
cell-matrix	NULL
interactions	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
:	NULL
29091-29098	NULL
.	NULL

2010	NULL
_	NULL
Guedez	NULL
et	NULL
al	NULL
.	NULL

43	NULL
.	NULL

Strasser	NULL
,	NULL
A.	NULL
,	NULL
A.W	NULL
.	NULL

Harris	NULL
,	NULL
D.C.	NULL
Huang	NULL
,	NULL
P.H	NULL
.	NULL

Krammer	NULL
,	NULL
and	NULL
S.	NULL
Cory	NULL
.	NULL

1995	NULL
.	NULL

Bcl-2	NULL
and	NULL
Fas/APO-1	NULL
regulate	NULL
distinct	NULL
pathways	NULL
to	NULL
lymphocyte	NULL
apoptosis	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:6136-	NULL
6147	NULL
.	NULL

44	NULL
.	NULL

Strasser	NULL
,	NULL
A	NULL
.	NULL

1995	NULL
.	NULL

Life	NULL
and	NULL
death	NULL
during	NULL
lymphocyte	NULL
development	NULL
and	NULL
function	NULL
:	NULL
evidence	NULL
for	NULL
two	NULL
distinct	NULL
killing	NULL
mechanisms	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

7	NULL
:	NULL
228-234	NULL
.	NULL

45	NULL
.	NULL

Chiu	NULL
,	NULL
V.K	NULL
.	NULL

,	NULL
C.M	NULL
.	NULL

Walsh	NULL
,	NULL
C.C	NULL
.	NULL

Liu	NULL
,	NULL
J.C.	NULL
Reed	NULL
,	NULL
and	NULL
W.R.	NULL
Clark	NULL
.	NULL

1995	NULL
.	NULL

Bcl-2	NULL
blocks	NULL
degranulation	NULL
but	NULL
not	NULL
fas-based	NULL
cell	NULL
mediated	NULL
cytotoxicity	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154:2023-2032	NULL
.	NULL

46	NULL
.	NULL

Memon	NULL
,	NULL
S.A.	NULL
,	NULL
M.B	NULL
.	NULL

Moreno	NULL
,	NULL
D.	NULL
Patrak	NULL
,	NULL
and	NULL
C.M	NULL
.	NULL

Zacarchuck	NULL
.	NULL

1995	NULL
.	NULL

Bcl-2	NULL
blocks	NULL
glucocorticoid-but	NULL
not	NULL
Fas-or	NULL
activation-induced	NULL
apoptosis	NULL
in	NULL
a	NULL
T	NULL
cell	NULL
hybridoma	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

155:4644-4652	NULL
.	NULL

47	NULL
.	NULL

Milner	NULL
,	NULL
A.E	NULL
.	NULL

,	NULL
G.D.	NULL
Johnson	NULL
,	NULL
and	NULL
C.D	NULL
.	NULL

Gregory	NULL
.	NULL

1992	NULL
.	NULL

Prevention	NULL
of	NULL
programmed	NULL
cell	NULL
death	NULL
in	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
lines	NULL
by	NULL
bel-2-dependent	NULL
and	NULL
independent	NULL
mechanisms	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
.	NULL

52:636-644	NULL
.	NULL

48	NULL
.	NULL

Schneider	NULL
,	NULL
T.J.	NULL
,	NULL
D.	NULL
Grillot	NULL
,	NULL
L.C	NULL
.	NULL

Foote	NULL
,	NULL
G.E	NULL
.	NULL

Nunez	NULL
,	NULL
and	NULL
T.L	NULL
.	NULL

Rothstein	NULL
.	NULL

1997	NULL
.	NULL

Bcl-x	NULL
protects	NULL
primary	NULL
B	NULL
cells	NULL
against	NULL
Fas-mediated	NULL
apoptosis	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:4834-4839	NULL
.	NULL

49	NULL
.	NULL

Henkel	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Machleidt	NULL
,	NULL
I.	NULL
Alkaly	NULL
,	NULL
M.	NULL
Kronke	NULL
,	NULL
Y.	NULL
Benn-Neriah	NULL
,	NULL
and	NULL
P.A	NULL
.	NULL

Bacuerle	NULL
.	NULL

1993	NULL
.	NULL

Rapid	NULL
proteolysis	NULL
of	NULL
is	NULL
necessary	NULL
for	NULL
activation	NULL
of	NULL
transcription	NULL
factor	NULL
NF-kB	NULL
.	NULL

Nature	NULL
.	NULL

365:182-185	NULL
.	NULL

